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Abbreviations?
?
ACA? Anterior?cerebral?artery?
ApoE? Apolipoprotein?E?
BCA? Brachiocephalic?artery?
BMT? Bone?marrow?transplantation?
CAD? Coronary?artery?disease?
CBF? Cerebral?blood?flow?
CCA? Common?carotid?artery?
CCR2? CC?chemokine?receptor?2?
CLC? Contralateral?cortex?
CLS? Contralateral?striatum?
CXCL1? Chemokine?(C?X?C?motif)?ligand?1?
DT? Diphtheria?toxin?
ELISA? Enzyme?linked?immunosorbent?assay?
FACS? Fluorescence?activated?cell?sorting?
FoxP3? Forkhead?box?P3?
GAPDH? Glyceraldehyde?3?phosphate?dehydrogenase?
GWAS? Genome?wide?association?study?
H&E? Hematoxylin?and?eosin?
HAT? Histone?acetyltransferase?
HDAC9? Histone?deacetylase?9?
HDRP? Histone?deacetylase?related?protein?
HPRT? Hypoxanthine?guanine?phosphoribosyl?transferase?
IC? Infarct?core?
IFN??? Interferon???
IL?10? Interleukin?10?
LDL? Low?density?lipoprotein?
LDLR? Low?density?lipoprotein?receptor?
LVS? Large?vessel?stroke?
MCA? Middle?cerebral?artery?
MCAo? Middle?cerebral?artery?occlusion?
MCP?1? Monocyte?chemoattractant?protein?1?
MEF2? Myocyte?enhancer?factor?2?
oxLDL? Oxidized?LDL?
PBMCs? Peripheral?blood?mononuclear?cells?
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PComA? Posterior?communicating?artery?
PFA? Paraformaldehyde?
PIR? Peri?infarct?region?
Rag?1? Recombination?activating?gene?1?
ROI? Region?of?interest?
SCA? Subclavian?artery?
SCID? Severe?combined?immunodeficiency?
SMC? Smooth?muscle?cell?
SNP? Single?nucleotide?polymorphism?
TGF??? Transforming?growth?factor???
TOAST? Trial?of?organization?10172?in?acute?stroke?treatment?
tPA? Tissue?plasminogen?activator?
Tregs? Regulatory?T?cells?
TUNEL? Terminal?deoxynucleotidyl?transferase?dUTP?nick?end?labeling?
VCAM?1? Vascular?cell?adhesion?molecule?1?
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1???Summary?
In?a?genome?wide?association?study?for? ischemic?stroke,?the?so?far?strongest?risk? locus?for?
large? vessel? stroke?was? identified? in? the? histone? deacetylase? 9? (HDAC9)? gene? region? at?
chromosome?7p21.1.?HDAC9?mRNA? levels?were?found?to?be? increased? in?peripheral?blood?
mononuclear?cells?of?healthy?risk?allele?carriers?of?the?lead?SNP?rs2107595,?suggesting?that?
increased?HDAC9?expression?enhances?the?risk?for?large?vessel?stroke.?These?findings?make?
HDAC9? a? promising? candidate? gene? for? atherosclerosis? and? stroke.? In? this? thesis,? we?
investigated?the?consequences?of?HDAC9?deficiency?on?atherosclerosis?and?ischemic?stroke?
outcome.?
ApoE?deficient?mice? (ApoE?/?)?were?used?as?a?model? for?atherosclerosis.?We?analyzed? the?
effects? of? HDAC9? deficiency? on? atherosclerotic? plaque? size? in? ApoE? deficient? mice? at?
different?ages?and?on?different?diets.?Compared? to?HDAC9+/+ApoE?/??mice,?HDAC9?/?ApoE?/??
mice? showed? reduced? atherosclerotic? lesion? sizes? and? less? advanced? lesions,?when? they?
were? fed? a? chow? diet.? However,? no? difference? was? observed? in? more? advanced?
atherosclerosis? after? a?high?cholesterol?Western?type?diet,? indicating? a?protective? role?of?
HDAC9? deficiency? in? early? atherogenesis.? Immunological? analyses? by? flow? cytometry?
showed?a?shift? in?monocyte?populations? from?classical,? inflammatory?monocytes? to?more?
resident?monocytes?in?HDAC9?/?ApoE?/??mice.?Moreover,?T?cell?analysis?revealed?a?reduction?
in?effector?memory?T?cells?in?chow?fed?HDAC9?/?ApoE?/??mice,?indicating?decreased?activation?
and?migration?of?T? cells.?These? findings? suggest? that?both? innate?and?adaptive? immunity?
play?an?important?role?in?the?atheroprotective?effect?of?HDAC9?deficiency.??
For? ischemic?stroke?outcome,?we?used?a?transient?focal? ischemia?model?which? is?based?on?
the?occlusion?of?the?middle?cerebral?artery?(MCAo)?for?one?hour,?using?a?filament?inserted?
via? the? internal?carotid?artery.? In?contrast? to? the?protective?effect?of?HDAC9?deficiency? in?
atherosclerosis,? HDAC9?/?? mice? showed? increased? infarct? volumes? and? more? severe?
neurological? deficits? 24? hours? as? well? as? 7? days? after?MCAo.? TUNEL? staining? revealed?
increased?cell?death?in?peri?ischemic?areas?of?HDAC9?/??mice,?indicating?a?protective?role?of?
HDAC9?in?the?brain?parenchyma.?
Our? results? suggest? a? pro?atherogenic? but? neuroprotective? role? of? HDAC9.? Specific?
pharmacological? inhibition? of? HDAC9? might? be? a? promising? strategy? to? prevent?
atherosclerosis,? but? not? to? improve? ischemic? stroke? outcome.? Thus,? potential? effects? of?
HDAC9?inhibitors?on?the?brain?have?to?be?considered.? ?
?
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2???Introduction?
2.1???Stroke?
Epidemiology?
Stroke? is?the?second?most?common?cause?of?death?worldwide?(Lozano?et?al.,?2012).?In?the?
United?States,?every?40?seconds?someone?has?a?stroke?and?every?4?minutes?someone?dies?
of? a? stroke? (Mozaffarian? et? al.,? 2015).? Incidence? for? stroke? varies? between? countries,?
ranging?worldwide?from?60?to?504?cases?per?100,000?people?per?year?(Feigin?et?al.,?2014).?In?
2010,?stroke?was?at?the?third?rank?of?major?causes?for?reduced?disability?adjusted?life?years?
(DALYs,?the?sum?of?years?of?life?lost?and?years?lived?with?disability)?(Murray?et?al.,?2012).?The?
lifetime?risk?for?stroke?is?1?out?of?5?women?and?1?out?of?6?men?(Seshadri?and?Wolf,?2007).?In?
2010,?total?European?costs?for?stroke?were?64.1?billion?Euros?(Olesen?et?al.,?2012).?Stroke?is?
an? increasing?health?problem?worldwide?because?of?demographic?changes?confronting?us?
with?an?aging?population.??
Stroke? is?characterized?by?neurological?deficits?which?are?based?on?an?acute?focal? injury?of?
the? central? nervous? system? due? to? a? vascular? cause? (Sacco? et? al.,? 2013)? and? can? be?
subdivided? into? ischemic? (80%)?and?hemorrhagic? stroke? (20%).?While?hemorrhagic? stroke?
results? from? a? rupture? of? a? vessel? leading? to? extravasation? of? blood,? ischemic? stroke? is?
caused?by? the?narrowing?or?occlusion?of?a?brain? supplying?artery,? for?example?due? to?an?
embolus?or?a?local?thrombus.?
?
Ischemic?stroke?subtypes?
Based? on? the?mechanism? causing? the? vessel? occlusion,? ischemic? stroke? can? be? classified?
according?to?the?pathophysiological?Trial?of?Organization?10172?in?Acute?Stroke?Treatment?
(TOAST)? criteria?as? cardioembolic? stroke,? large? vessel? stroke? (LVS),? small? vessel?occlusion?
(lacunes),?stroke?of?other?determined?etiology?or?stroke?of?undetermined?etiology?(Adams?
et? al.,?1993)? (Figure?1).?Cardioembolic? stroke? is? induced?by? an? embolus? arising? from? the?
heart,? for?example?as?a? result?of?atrial? fibrillation.? In?patients?with? LVS?one?of? the?major?
brain?arteries?or?branch?cortical?arteries?is?occluded?or?has?a?significant?stenosis?(>?50%)?by?
atherosclerotic?plaques.?Stroke?due? to?small?vessel?disease? (microangiopathy?of? the?small?
cerebral?vessels?including?small?arteries,?arterioles,?capillaries?and?venules)?is?characterized?
?
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by?subcortical?or?brainstem? infarcts?(diameter? less?than?1.5?cm),?collectively?called? lacunar?
infarcts.?
?
?
Figure?1.?Etiology?of?ischemic?stroke.?
Frequencies? are? taken? from? the? Stroke?Data?Bank?of? the?German? Stroke? Foundation? (Grau?et? al.,?
2001).?
?
Therapy?of?ischemic?stroke?
In? acute? ischemic? stroke,? the?most? effective? treatment? after? exclusion? of? a? hemorrhagic?
cause? by? CT? (computed? tomography)? scan? is? thrombolysis? by? recombinant? tissue?
plasminogen?activator?(tPA)?to?recanalize?the?vessel?and?reperfuse?the?brain?(The?National?
Institute?of?Neurological?Disorders?and?Stroke? rt?PA?Stroke?Study?Group,?1995).?The? time?
window?of?only?4.5?hours?after?stroke?onset?is?essential?for?this?therapy?(Hacke?et?al.,?2008).?
Recent? studies? showed? that? tPA? in? combination? with? stent? retriever? thrombectomy?
improves? functional? outcome? in? comparison? to? tPA? medication? alone,? which? is? a?
breakthrough? in? acute? stroke? management? (Jovin? et? al.,? 2015;? Saver? et? al.,? 2015).? As?
secondary? prevention? of? recurrent? stroke,? patients? receive? antiplatelet? agents? such? as?
aspirin?and?dipyridamole,? statins? for? treating?hypercholesterolemia?and?anticoagulants? in?
case?of?atrial?fibrillation.?When?stenosis?of?the?symptomatic?carotid?artery? is?at? least?70%,?
carotid?endarterectomy? is?performed?(Donnan?et?al.,?2008).?Specific?treatment?options?for?
stroke?are?still?limited,?since?disease?mechanisms?are?poorly?understood.?
? ?
?
?
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Genetics?of?ischemic?stroke?
Ischemic? stroke? is? a? heterogeneous? multifactorial? disease.? Modifiable? risk? factors?
(hypertension,? smoking,?diabetes,?atrial? fibrillation?and?obesity)?and?acquired? risk? factors?
(age,?gender?and?race?ethnicity)?can?explain?part?of?the?stroke?risk,?but?from?twin?and?family?
studies?we?know? that?also?genetic? factors?play?a? substantial? role? (Goldstein?et?al.,?2006).?
Twin?studies?showed?that?the?concordance?rate?for?stroke?is?fivefold?higher?in?monozygotic?
twins? than? in? dizygotic? twins? (Brass? et? al.,? 1992).? The? heritability? of? ischemic? stroke? is?
estimated? at? 37.9%,? but? varies? for? the? different? subtypes:? 40.3%? for? LVS,? 32.6%? for?
cardioembolism,?and?16.1%?for?small?vessel?disease?(Bevan?et?al.,?2012).?These?differences?
emphasize?the?importance?of?stroke?subtyping?for?identifying?genetic?associations.??
To?discover?novel?genetic?components?influencing?ischemic?stroke?risk,?two?approaches?are?
commonly?used:?candidate?gene?association?studies?(Hirschhorn?et?al.,?2002)?and?genome?
wide? association? studies? (GWAS)? (Wang? et? al.,? 2005).? Both? approaches? make? use? of?
common? (frequency? >1%)? genomic? variants? usually? affecting? a? single? nucleotide? (single?
nucleotide? polymorphisms,? SNPs)? to? identify? disease? risk? genes.? The? majority? of? these?
variants?has?no?consequences?on?protein?sequences?or?expression.?However,?some?of?them?
are? located? in? coding? regions? and? can? cause? amino? acid? exchanges? altering? protein?
structure,?others?are?situated?in?regulatory?regions?and?might?influence?gene?expression.?In?
both?cases,?this?might?result? in?an? increased?disease?risk.? In?the?candidate?gene?approach?
the? frequencies?of? variants? in?a? known?gene?are? compared?between? stroke?patients?and?
controls,?but?in?the?past?only?very?few?hits?have?been?successfully?replicated,?probably?due?
to? small? sample? sizes,?poor? stroke? subtype? classification? and? study?design? (Dichgans? and?
Markus,?2005).?Therefore,?current?research? focuses?more?and?more?on?GWAS? in?order? to?
identify? risk? loci? in? complex? diseases.? Here? a? large? number? of? variants? from? the?whole?
genome?are?compared?between?cases?and?controls.?Some?of?them?might?have?an?impact?for?
example?on?stroke?risk?by?affecting?conventional?risk?factors?such?as?hypertension?(Marteau?
et? al.,? 2005)? or? by? modulating? diseases? including? atherosclerosis? (Lusis? et? al.,? 2004;?
Stylianou?et?al.,?2012).?But?they?could?also?influence?infarct?size?or?stroke?outcome,?making?
GWAS?a?highly?promising?approach?to?identify?novel?risk?factors.?
? ?
?
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2.2???A?new?risk?locus?for?large?vessel?stroke???the?7p21.1?region?
As? part? of? the? International? Stroke? Genetics? Consortium? and? the?Wellcome? Trust? Case?
Control?Consortium?2,?we? recently?contributed? to?a?GWAS? conducted?on? ischemic? stroke?
(Bellenguez? et? al.,? 2012).? 495,851? SNPs?were? analyzed? in? 3,548? stroke? cases? and? 5,972?
controls,? all? of? European? ancestry.? Stroke? cases?were? classified? according? to? the? TOAST?
classification? into? LVS,? cardioembolism,? and? small? vessel? disease.? Previous? risk? loci? for?
cardioembolic? stroke? (PITX2? and? ZFHX3)? (Gretarsdottir? et? al.,? 2008;? Gudbjartsson? et? al.,?
2009;? Lemmens?et?al.,?2010)?and?one? locus? for? LVS? (9p21.3)? (Gschwendtner?et?al.,?2009)?
could?be?replicated.?Additionally,?a?novel?locus?for?LVS?at?the?7p21.1?region???the?strongest?
risk?locus?for?this?stroke?subtype?to?date???was?identified?and?replicated?in?an?independent?
cohort? (Bellenguez?et?al.,?2012).?The?METASTROKE?collaboration?could?confirm? this?novel?
risk?locus?in?a?combined?data?set?from?available?GWAS?with?12,389?stroke?cases?and?62,004?
controls?from?15?different?populations,?all?of?European?ancestry?(Traylor?et?al.,?2012).?In?the?
METASTROKE?study,?the?rs2107595?SNP?was?the?most?significant?variant?with?a?P?value?of?
2.03×10?12.?The?population?attributable?risk?was?estimated?to?be?4.5%,?the?odds?ratio?was?
1.39?(95%?CI:?1.27???1.53)?and?the?risk?allele?frequency?was?16%?(Traylor?et?al.,?2012).?The?
7p21.1? locus?encompasses?the?3’?end?of?the?histone?deacetylase?9? (HDAC9)?gene?and?the?
intergenic?region?between?HDAC9?and?its?neighboring?genes,?TWIST1?and?FERD3L?(Figure?2).?
?
?
?
?
?
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?
Figure?2.?Plot?of?association?signals?in?the?7p21.1?region.?
rs2107595,? the? lead? SNP? from? the? METASTROKE? data? set? (Traylor? et? al.,? 2012),? and? all? other?
associated?signals?are?located?at?the?3’?end?of?the?HDAC9?gene?and?in?the?intergenic?region?between?
HDAC9?and?the?neighboring?genes,?TWIST1?and?FERD3L.?Figure?adapted?from?Azghandi?et?al.,?2015.?
?
The?same?locus?was?found?by?the?CARDIOGRAM?Consortium?to?be?associated?with?coronary?
artery?disease? (CAD)?and?myocardial? infarction? (Deloukas?et?al.,?2013).?This? is? in? line?with?
the? strong?overlap?of? genetic? susceptibility?between? ischemic? stroke,? especially? LVS,? and?
CAD? (Dichgans? et? al.,? 2014).?Moreover,? several? variants?within? the? 7p21.1? region? show?
association?with? both? conditions,? indicating? that? they? act? through? a? shared?mechanism.?
Since? LVS?and?CAD?are?both?primarily? caused?by?atherosclerosis,? the?7p21.1? region? likely?
represents?a?risk?locus?for?this?disease.?
?
2.3???Atherosclerosis?
Development?of?atherosclerotic?plaques?
Atherosclerosis? is? the?major? contributor? to? cardiovascular? disease? including? stroke? and?
myocardial? infarction.? It? is? a? progressive? inflammatory? disease? of? the? arterial? wall?
characterized?by?accumulation?of? intra??and?extracellular? lipids?and?fibrous?material? in?the?
inner? lining?of?arteries,? the? tunica? intima.?The?word?“atherosclerosis”? is?derived? from? the?
Greek?words? “athera”? (gruel)?and? “sklerosis”? (hardening).?Until? the?1970s?atherosclerosis?
has? been? considered? as? a? disease? of? lipid? deposition? since? there? is? a? strong? correlation?
?
?
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between? hyperlipidemia? and? atherosclerosis? (Ross? and? Harker,? 1976).? But? in? the? past?
decades?the?involvement?of?both?innate?and?adaptive?immunity?became?clear.?
Atherosclerosis?develops?in?several?steps?(Figure?3).?The?anatomy?of?a?normal?arterial?wall?is?
shown? in?Figure?3A.?The? initiating? step? in?atherosclerosis? is?endothelial?activation?due? to?
endothelial? injury,?hyperlipidemia?or?pro?inflammatory?mediators.?Low?density? lipoprotein?
(LDL)? infiltrating? the? tunica? intima? can? be? modified? by? oxidation? and? induces? an?
inflammatory? response? of? the? endothelium? (Skalen? et? al.,? 2002;? Hansson,? 2005).? This?
subendothelial?retention?of?lipoproteins?by?the?extracellular?matrix?leads?to?the?expression?
of? endothelial? adhesion? molecules? (Nakashima? et? al.,? 1998)? and? the? recruitment? of?
leukocytes? to? the? tunica? intima? (Figure?3B).?Monocytes? infiltrate? the? intima,?differentiate?
into? tissue? macrophages? and? take? up? lipoproteins,? including? oxidized? LDL.? These?
macrophages?become?foam?cells,?a?histological?term?derived?from?their? lipid? laden,?foamy?
appearance.?Early?atherosclerotic? lesions,? called? “fatty? streaks”,? consist?of? subendothelial?
accumulation?of?foam?cells?(Figure?3C)?and?can?already?be?found?in?the?aorta?of?children?in?
the?first?decade?of? life?(Lusis,?2000).?These? lesions?have?no?clinical?relevance,?but?they?can?
progress? to? advanced? lesions?which? form?mainly? at?branch?points?of? arteries?because?of?
blood? flow? turbulences? (Lusis,?2000).?Advanced? lesions?are?characterized?by?a? fibrous?cap?
formed? by? smooth?muscle? cells? and? extracellular?matrix,? a? lipid?rich? necrotic? core? and?
surrounding?leukocytes?of?the?innate?and?adaptive?immunity?(Figure?3D?and?3E).?
The?necrotic?core?consists?of?dying?foam?cells?which?release?their?lipid?content?and?thereby?
contribute? to? the?excess?of?extracellular? lipids? in? the? lesion.?Smooth?muscle?cells?migrate?
from? the? tunica?media? into? the? intimal? lesion,? secreting?extracellular?matrix? components?
and? thereby? increasing? the? lesion? size.? Initially,? the?atherosclerotic?plaque?grows? into? the?
direction?of? the? tunica? adventitia,?but? after? reaching? a? critical?point? it? grows? toward? the?
blood?vessel?lumen?resulting?in?a?decrease?in?vessel?diameter.?A?plaque?can?grow?gradually?
until? it? reduces? the?blood? flow? in?a?vessel,? leading? to?a? stenosis.?But? the?most? important?
complication? of? atherosclerosis? is? plaque? rupture,?which? exposes? procoagulant?material?
often?leading?to?a?local?thrombus?or?an?embolus?occluding?a?distal?artery.?The?thickness?of?
the? fibrous?cap,?grade?of? inflammation,?and?necrotic?core? size?are?critical?parameters? for?
rupture?prone,?so?called?vulnerable?plaques?(Finn?et?al.,?2010).??
?
?
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Figure?3.?Stages?in?the?development?of?atherosclerosis.?
A,? Scheme? of? a? normal,? healthy? artery? consisting? of? three? layers,? the? tunica? intima? with? the?
endothelium,?the?tunica?media?with?vascular?smooth?muscle?cells?(SMCs),?and?the?tunica?adventitia?
with?connective?tissue.?B,?The?initial?step?of?atherogenesis?is?the?expression?of?endothelial?adhesion?
molecules?after?endothelial?activation,? the? subsequent?adhesion?and?migration?of?monocytes? into?
the? tunica? intima? and? their? differentiation? into? macrophages.? C,? Macrophages? phagocytose?
lipoprotein?particles,?become? foam?cells?and? form?so?called? fatty?streaks.?SMCs?migrate?out?of?the?
tunica?media?into?the?tunica?intima.?D,?SMCs?produce?extracellular?matrix?molecules?such?as?collagen?
and? start? to? form?a? fibrous? cap.?E,?Apoptosis?of? foam? cells?and?SMCs? leads? to? the? formation?of?a?
necrotic?core?with?extracellular? lipids.?An?advanced?atheroma?develops?with?a?fibrous?cap?covering?
the?necrotic,?lipid?core.?
?
?
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Mouse?models?of?atherosclerosis?
Animal?models? of? atherosclerosis? have? been? developed? in? a? variety? of? species? including?
rabbits,?pigs?and?non?human?primates.?However,?the?most? important?and?most?commonly?
used? laboratory?model? is? the?mouse? (Getz?and?Reardon,?2012).?Under?normal?conditions?
wild?type?mice?do?not?develop?atherosclerotic?lesions,?but?deletion?of?the?apolipoprotein?E?
(ApoE)? gene? leads? to? spontaneous? atherosclerotic? plaque? formation? (Plump? et? al.,? 1992;?
Nakashima? et? al.,? 1994).? Atherogenesis? in? this?model? is? accelerated? by? feeding? a? high?
cholesterol? diet,? for? example? a?Western?type? diet? (Figure? 4).? Another?mouse?model? for?
atherosclerosis? is?based?on? low?density? lipoprotein?receptor?(LDLR)?deficiency.?These?mice?
have?to?be?fed?a?high?cholesterol?diet?to?develop?atherosclerotic?plaques.?Although?the?sites?
of? lesion? formation? in? both?mouse?models? (aortic? root,? aortic? arch? and? brachiocephalic?
artery)? are? different? from? humans? (coronary,? carotid? and? periphery? arteries)? (Getz? and?
Reardon,? 2012),? plaque? types? and? phases? of? their? development? are? highly? comparable?
(Figure? 4).?However,? the? process? of? atherothrombosis? due? to? plaque? rupture? cannot? be?
studied?in?mouse?models?since?vulnerable?plaques?do?not?develop.?Nevertheless,?the?results?
of? studies? in?mouse?models?have? strongly?advanced?our?understanding?of?atherosclerotic?
processes.? Both? the? ApoE?/?? and? the? LDLR?/??model? are? widely? used? to? test? therapeutic?
options?for?atherosclerosis?or,?after?breeding?them?to?other?transgenic?or?knockout?mice,?to?
study?the?role?of?different?factors,?e.g.?components?of?the?immune?system?in?atherogenesis.?
In?addition,?bone?marrow?transplantation? into?ApoE?/??or?LDLR?/??mice?can?be?performed?to?
investigate? the? contribution? of? bone? marrow? derived? cells.? Collectively,? advantages? of?
possible?genetic?manipulation?as?well?as?short?breeding? times?and?relatively? low?costs? for?
husbandry? in? comparison? to? other? mammalian? species? make? the? mouse? the? most?
frequently?used?and?favored?model?in?atherosclerosis?research.?
?
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Figure?4.?Timeline?of?atherosclerotic?lesion?development?in?ApoE?deficient?mice.?
Feeding?a?high?cholesterol?Western?type?diet?accelerates?atherogenesis?in?comparison?to?a?standard?
chow?diet?(adapted?from?Nakashima?et?al.,?1994).??
?
Role?of?the?immune?system?in?atherosclerosis?
The? immune? system? plays? an? important? role? in? the? initiation,? the? progression,? and? the?
rupture? of? atherosclerotic? lesions.? The? perception? of? atherosclerosis? as? a? chronic?
inflammatory? disease? has? replaced? the? earlier? concept? which? focused? entirely? on? lipid?
metabolism?(Weber?et?al.,?2008).?A?wide?range?of?immune?cell?mediated?cascades?promote?
atherosclerosis.?For?instance,?vascular?cell?adhesion?molecule?1?(VCAM?1)?has?a?major?role?
in? the? initiation? of? atherosclerosis? as? an? early? endothelial?leukocyte? adhesion?molecule?
(Cybulsky?and?Gimbrone,?1991;?Cybulsky?et?al.,?2001).?VCAM?1?selectively?binds?monocytes?
and? lymphocytes,? the?predominant? leukocyte?subtypes? in?atherosclerotic?plaques,?and? its?
expression?increases?in?response?to?hypercholesterolemia?at?lesion?prone?sites?of?the?aorta?
(Nakashima? et? al.,? 1998).? Diphtheria? toxin? (DT)?mediated? depletion? of? monocytes? in? a?
CD11b?DT?receptor? transgenic?mouse?model? led? to?a?significant?reduction?of?early?plaque?
formation,?whereas?DT? application?had?no?effect?on? size? and? composition?of?established?
plaques,? suggesting? that? monocytes? play? an? important? role? in? early? atherogenesis?
(Stoneman?et?al.,?2007).?Different?subsets?of?monocytes?can?be?distinguished?according?to?
their?expressed?chemokine?receptors:?the?short?lived?inflammatory?(CX3CR1low?CCR2+?Ly6Chi)?
subset? and? the? resident? subset? (CX3CR1hi? CCR2?? Ly6Clow)? which? represent? patrolling?
monocytes?on?healthy?endothelium?and? react? immediately? to?an? infection?by? inducing?an?
early? immune?response? (Auffray?et?al.,?2007;?Weber?et?al.,?2008).? It?has?been?shown? that?
hypercholesterolemia? increases? numbers? of? blood? circulating? Ly6Chi? monocytes,? which?
?
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infiltrate? lesions? of? atherosclerotic? mice? (Swirski? et? al.,? 2007).? Chemokines? like? the?
monocyte? chemoattractant? protein?1? (MCP?1/CCL2)? play? an? important? role? in? the?
recruitment?and?migration?of?monocytes? into? the? tunica? intima.?Absence?of?MCP?1?or? its?
receptor,? CC?chemokine? receptor? 2? (CCR2)? leads? to? decreased? atherosclerotic? lesion?
formation? in? experimental? atherosclerosis?models? (Boring? et? al.,? 1998;? Gu? et? al.,? 1998).?
Monocytes? in? the? tunica? intima?differentiate? to?macrophages? in? response? to?macrophage?
colony?stimulating? factor? (M?CSF),? produced? by? endothelial? and? smooth? muscle? cells?
(Rajavashisth?et?al.,?1990).?
Besides?monocytes/macrophages,?T?cells,?dendritic?cells,?mast?cells,?B?cells,?and?neutrophils?
are? present? in? atherosclerotic? plaques.?Macrophages? and? CD4+? T? helper? cells? as?well? as?
CD8+? cytotoxic? T? cells? are? the?predominant? immune? cell? types?of?human? atherosclerotic?
plaques?(Jonasson?et?al.,?1986;?Stemme?et?al.,?1992).?Initially,?it?was?thought?that?T?cells?are?
not?playing?a?major?role?in?atherosclerosis?based?on?studies?showing?that?ApoE?/??mice?with?
a? strongly? compromised? immune? system? ?? because? of? inactivation? of? the? recombination?
activating?gene?1?(Rag?1)???have?unchanged?atherosclerotic?lesion?sizes?when?fed?a?Western?
type?diet.?But?when?a?normal?chow?diet?was?used,?they?showed?a?42%?reduction? in? lesion?
size? (Dansky? et? al.,? 1997).? Similarly,? immunodeficient?ApoE?/?/scid/scid?mice? show? a? 73%?
reduction? in? lesion? size? under? chow? diet? (Zhou? et? al.,? 2000).? An? adoptive? transfer? of??
CD4+? T? cells? into? ApoE?/?/scid/scid?mice? aggravates? atherosclerosis? to? almost? the? same?
degree? as? in? immunocompetent? ApoE?/??mice.? Type? 1? T? helper? (TH1)? cells? are? the?most?
prevalent?T?cell?subtype? in?human?atherosclerotic? lesions?(Frostegard?et?al.,?1999)?and?the?
pro?inflammatory?cytokine?interferon???(IFN??),?which?is?secreted?by?TH1?cells,?appears?to?be?
proatherogenic? (Whitman? et? al.,? 2000;? Zhou? et? al.,? 2000).? Analysis? of? the? T? cell? antigen?
receptors? expressed? in? atherosclerotic? lesions? showed? a? restricted? pattern,? suggesting?
oligoclonal?T?cell?expansion?and?specific?antigen?processes? in?atherosclerosis? (Paulsson?et?
al.,?2000).?Isolated?T?cells?from?human?atherosclerotic?plaques?react?to?oxLDL,?making?this?
metabolite?a?prime?candidate?antigen? for?atherosclerosis? specific? inflammatory?processes?
(Stemme?et?al.,?1995).??
But? some? immune? cell? types? and? cytokines? from? the? adaptive? immunity? show? also?
atheroprotective?properties?like?regulatory?T?cells?(Tregs)?and?their?cytokines?interleukin?10?
(IL?10)?and?transforming?growth?factor???(TGF??).?Tregs?are?T?cells?with?immunosuppressive?
functions?and?essential?for?maintaining?self?tolerance?and?the?prevention?of?autoimmunity.?
?
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They? can? be? generated? in? the? thymus? as? naturally? occurring? Tregs? or? induced? in? the?
periphery?from?naïve?CD4+?T?cells?(Ait?Oufella?et?al.,?2014).?Tregs?are?characterized?by?the?
expression? of? the? forkhead/winged? helix? transcription? factor? FoxP3.? It? was? shown? that?
inhibition?or?deficiency?of? the? Treg? cytokines? IL?10? and? TGF??? aggravates? atherosclerosis?
(Mallat?et?al.,?1999;?Mallat?et?al.,?2001).? Furthermore,?depletion?of?Tregs?by?neutralizing?
antibody?treatment?or?by?diphtheria?toxin?increases?atherosclerosis?significantly?(Ait?Oufella?
et?al.,?2006;?Klingenberg?et?al.,?2013),?making?Tregs?an? interesting? target? for? therapeutic?
intervention.?
In? the? last? years,? also? the? role? of? neutrophils? has? been? intensely? investigated? in?
atherosclerosis.? It? could? be? shown? that? neutrophils? are? present? in? early? and? advanced?
atherosclerotic?lesions?in?experimental?mouse?models?(van?Leeuwen?et?al.,?2008;?Drechsler?
et?al.,?2010;?Rotzius?et?al.,?2010)?as?well?as? in?human?atherosclerotic?plaques?(Ionita?et?al.,?
2010).? Plasma? levels? of? neutrophil? granule? proteins? such? as?myeloperoxidase? (MPO)? are?
candidates?for?biomarkers,?for?example?to?predict?coronary?artery?disease?risk?(Zhang?et?al.,?
2001).??
In? summary,? the? immune? system? is? a?major? driver? of? atherosclerosis? development? and?
represents? an? important? target? for? therapeutic? intervention.? However,? the? molecular?
players? involved? in? the? inflammatory? processes? contributing? to? atherosclerosis? are?
incompletely?described.?The?GWAS? approach? is?highly? suited? to? identify?novel? treatment?
targets?for?atherosclerosis.?
?
2.4???Candidate?genes?at?the?7p21.1?locus?
The? 7p21.1? locus? is? the? so? far? strongest? risk? locus? for? large? vessel? stroke.? However,? all?
identified?SNPs?are?localized?in?intronic?or?intergenic?regions?making?an?explanation?for?the?
underlying? molecular? mechanisms? difficult.? The? 7p21.1? region? contains? three? potential?
candidate?genes,?HDAC9,?TWIST1?and?FERD3L?(see?Figure?2).?
TWIST1?and?FERD3L?code?for?transcription?factors?of?the?helix?loop?helix?family?involved?in?
cell? differentiation? processes? during? embryogenesis.? The? factor? Nato3? encoded? by? the?
FERD3L?gene? is? dynamically? expressed? in? the? floor? plate? of? the? neural? tube? during? both?
midbrain? (Ono?et?al.,?2010)?and? spinal?cord?development? (Mansour?et?al.,?2014).?TWIST1?
plays?an? important?role? in?the?differentiation?of?mesenchymal?stem?cells? in?chondrocytes,?
adipocytes?and?osteoblasts?(Miraoui?and?Marie,?2010).?Additionally,?pathological?conditions?
?
?
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of? TWIST1? are? known.? Mutations? in? humans? cause? the? autosomal? dominant??
Saethre?Chotzen? syndrome? (SCS),? also? called? acrocephalosyndactyly? III? (ACS? III),?which? is?
characterized?by?facial?dysmorphism,? limb?abnormalities,?and?craniosynostosis?(El?Ghouzzi?
et?al.,?1999).??
HDAC9? belongs? to? the? evolutionary? conserved? family? of? histone? deacetylases? (HDACs)?
which? together? with? the? histone? acetyltransferases? (HATs)? regulate? the? acetylation? of?
histone? and? non?histone? proteins? and? play? important? roles? in? several? physiological? and?
pathological?conditions? (Haberland?et?al.,?2009).?HDAC9? is?mainly?expressed? in? the?heart,?
brain,? and?muscle.?HDACs? are? also? known? to?be? involved? in? inflammation? and? immunity?
(Shakespear?et?al.,?2011),?which?play?an?important?role?in?atherosclerosis.?
To? investigate?which?of? the? three? genes?might? be? responsible? for? the? association?of? the?
7p21.1?locus?with?LVS,?my?colleague?Caroline?Prell?Schicker?quantified?their?mRNA?levels?in?
peripheral? blood?mononuclear? cells? (PBMCs)? of? healthy? blood? donors.? HDAC9,? but? not?
TWIST1? or? FERD3L,? was? found? to? be? elevated? in? risk? allele? carriers? of? the? lead? SNP?
rs2107595?(see?Figure?5?and?manuscript?1?of?this?thesis)?(Azghandi?et?al.,?2015).?This?made?
HDAC9?the?most?promising?candidate?gene?in?the?7p21.1?region?and?indicated?that?it?has?an?
atherogenic?role.?
?
?
Figure?5.?Expression? levels?of?HDAC9,?but?not?of?TWIST1?and?FERD3L,?are? increased? in?peripheral?
blood?mononuclear?cells?of?healthy?homozygous?and?heterozygous?risk?allele?(A)?carriers.??
Relative?mRNA?expression?levels?of?HDAC9,?TWIST1?and?FERD3L?in?healthy?subjects?in?respect?to?the?
rs2107595?genotype.?*P<0.05,?**P<0.01,?n.s.?not?significant.?Figure?from?Azghandi?et?al.,?2015.?
?
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2.5???Histone?deacetylases?
Histones?are? the?most? important? components?of? chromatin?and? thus?major? regulators?of?
gene? transcription.?Within? their?N?terminal?domains? they? contain? a?number?of?positively?
charged? basic? amino? acids?which? interact?with? the? negatively? charged?DNA?backbone? to?
promote?chromatin?condensation.?Such?compacted?DNA? is? inaccessible?for?binding?factors?
and? thus? transcriptionally? silent.? Posttranslational? modification? of? histones? such? as?
acetylation? and? methylation? has? been? known? since? the? 1960s? to? control? chromatin?
structure? (Allfrey? et? al.,? 1964).? For? example? acetylation? of? the? ??amino? group? of? lysine?
residues?within?histone?tails?relaxes?chromatin?structure?by?neutralizing?the?positive?charge.?
This? results? in? increased? accessibility?of?genomic?DNA? for? transcription? regulating? factors?
(Shahbazian? and? Grunstein,? 2007).? Two? families? of? enzymes,? the? histone? deacetylases?
(HDACs)?and?histone?acetyltransferases?(HATs),?regulate?the?acetylation?and?deacetylation?
of?histones? (Figure?6),?but?also?of?non?histone?proteins? including?transcription?factors?and?
heat?shock?proteins.?One?of?their?main?functions?is?the?regulation?of?chromatin?remodeling?
and? gene? expression? (Shahbazian? and?Grunstein,? 2007).?HDACs? and?HATs? are? regulating?
diverse?developmental?processes,?but? are? also? involved? in?physiological? and?pathological?
processes?in?the?adult?organism?(Haberland?et?al.,?2009).??
?
Classification?of?HDACs?
The?18?members?of?the?HDAC?family?can?be?grouped?into?four?classes?(I,?II,?III?and?IV),?based?
on?sequence?homology?and?domain?organization.?Class? I,? II?and? IV?are?the?classical?HDACs?
which?use?Zn2+?as?a?cofactor?whereas?class?III?HDACs,?the?sirtuins?1?7,?are?NAD+?dependent?
(Shakespear? et? al.,? 2011).? Class? I? consists? of? HDAC1,? HDAC2,? HDAC3? and? HDAC8?which?
localize? to? the? nucleus? and? are? expressed? ubiquitously.? HDAC9? belongs,? together? with?
HDAC4,?HDAC5?and?HDAC7,? to?class? IIa?HDACs?which?have?an?N?terminal?binding?domain?
mediating? the? interaction?with? transcriptional? repressors? and? activators? such? as?myocyte?
enhancer?factor?2?(MEF2)?(Haberland?et?al.,?2009).?Class?IIa?HDACs?can?shuttle?between?the?
nucleus? and? cytoplasm,? a?process? regulated?by? phosphorylation? through? kinases? such? as?
calcium/calmodulin?dependent? protein? kinase? (CaMK)? and? binding? of? 14?3?3? proteins?
(McKinsey?et?al.,?2000).?In?contrast?to?class?I?HDACs,?class?IIa?HDACs?have?a?more?restricted?
tissue?expression?pattern,?for?example?HDAC5?and?HDAC9?show?a?strong?expression?in?the?
brain,? the?heart,?and? the?muscle? (Zhang?et?al.,?2002;?Chang?et?al.,?2004).?Furthermore,? it?
?
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was? shown? that? class? IIa? HDACs? have? a? lower? deacetylase? activity? in? comparison? to??
class? I? HDACs? (Lahm? et? al.,? 2007).? However,? class? IIa? HDACs? can? recruit? class? I? HDACs,?
thereby?acquiring? increased?enzymatic?capacity? (Fischle?et?al.,?2002).?The?class? IIb?HDACs?
encompass? HDAC6? and? HDAC10.? HDAC6? is? a? cytoplasmic? HDAC? with? two? deacetylase?
domains?which? interacts?with?cytoskeletal?proteins,?e.g.?tubulin? (Matsuyama?et?al.,?2002).?
Class?IV?HDACs?consist?of?HDAC11?about?which?little?is?known.?
?
?
Figure?6.?Histone?deacetylases?and?histone?acetyltransferases.?
Histone? acetylation? is? controlled? by? two? families? of? enzymes,? the? histone? deacetylases? and? the?
histone?acetyltransferases.?Positively?charged???amino?groups?of? lysine?residues?within?histone?tails?
interact? with? the? negatively? charged? DNA? backbone? to? promote? compaction? of? the? chromatin?
structure.?Acetylation?of?these?groups?disrupts?interactions?and?results?in?chromatin?relaxation?which?
is?required?for?transcription?to?occur.?Deacetylation?reverses?this?process?resulting?in?transcriptional?
repression.?
?
HDAC?functions?
The? roles? of? HDACs? were? studied? in? several? disease? models? including? cardiovascular?
diseases? such? as? cardiac? hypertrophy? and? neointima? formation? as? well? as? neurological?
diseases? such? as?Huntington`s? disease? and? stroke.? Cardiac? hypertrophy? is? a? response? of?
cardiomyocytes? to? stimuli? like? hypertension? or? valvular? dysfunction.? Deficiency? of? the??
?
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class? IIa?HDACs?5?and?9?was? shown? to?promote? cardiac?hypertrophy? (Zhang?et?al.,?2002;?
Chang?et?al.,?2004).? In?contrast,?pan?HDAC? inhibitors?and?class? I?selective?HDAC? inhibitors?
can?prevent?and?even? reverse? cardiac?hypertrophy? suggesting? that? class? I?HDACs?oppose?
class?II?function?in?the?regulation?of?cardiac?hypertrophy?(Kook?et?al.,?2003;?Kee?et?al.,?2006).?
The? role?of?HDACs?was?also?studied? in?vascular?smooth?muscle?cells?and?endothelial?cells?
which? are? both? important? cell? types? for? atherosclerosis? and? neointima? formation.?HDAC?
inhibition?prevents?mitogen?induced?proliferation?of?smooth?muscle?cells?by?inducing?G1?cell?
cycle? arrest? (Findeisen? et? al.,? 2011).? Furthermore,? different? HDAC? inhibitors? attenuated?
neointima? formation? in? vivo? (Findeisen? et? al.,? 2011;? Kee? et? al.,? 2011),?making?HDACs? an?
interesting? target? for? vascular? remodeling? and? atherosclerosis.? HDAC3? has? prosurvival?
functions? in? endothelial? cells? and? knockdown? of? HDAC3? in? endothelial? cells? of? aortic?
isografts? leads? to?severe?atherosclerosis?and?vessel?rupture,?demonstrating? that?HDAC3? is?
critical? for? endothelial? cell? function? (Zampetaki? et? al.,? 2010).? HDAC4? was? shown? to? be?
associated? with? carotid? intima?media? thickness,? indicating? an? involvement? of? HDAC4? in?
atherosclerosis?(Lanktree?et?al.,?2009).??
Besides? beneficial? effects? in? cancer? and? cardiovascular? diseases,? HDAC? inhibitors? show?
neuroprotective?properties?in?neurological?and?neurodegenerative?diseases?(Kazantsev?and?
Thompson,? 2008),? like? Huntington`s? disease? (Ferrante? et? al.,? 2003;? Kazantsev? and?
Thompson,?2008)?and?stroke?(Faraco?et?al.,?2006;?Kim?et?al.,?2007).?Several?HDAC?inhibitors?
led?to?reduced?infarct?volumes?and?ameliorated?functional?outcome?in?experimental?animal?
stroke? models? (Kim? et? al.,? 2007;? Langley? et? al.,? 2008).? Proposed? mechanisms? include?
suppression?of?inflammation?(Kim?et?al.,?2007)?and?increased?expression?of?neuroprotective?
factors? like? heat? shock? protein? 70? (Hsp70),? B?cell? lymphoma? 2? (Bcl?2),? gelsolin? and?
phosphorylated?Akt?(Faraco?et?al.,?2006;?Kim?et?al.,?2007;?Yildirim?et?al.,?2008).??
Inhibition? of? HDACs? is? a? promising? approach? to? control? pathological? processes.? Several?
HDAC? inhibitors?have?been?developed?and?already?tested? in?preclinical?models?and?clinical?
trial?settings.?Known? inhibitors?can?be?subdivided? into? four?classes,? the?hydroxamic?acids,?
short? chain? fatty? acids,? cyclic? tetrapeptides,? and? benzamides.? Most? of? the? currently?
available?HDAC?inhibitors?inhibit?multiple?members?of?the?HDAC?family?and?are?thus?mostly?
non?selective.?HDAC?inhibitors?were?originally?found?as?anticancer?therapeutics?by?inducing?
apoptosis,?differentiation,?but?also?by?reducing?proliferation?and?angiogenesis? (Falkenberg?
and? Johnstone,?2014).?Some?HDAC? inhibitors?have?already?been?approved? for?therapeutic?
?
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treatment,? e.g.? suberoylanilide? hydroxamic? acid? (SAHA,? vorinostat)? for? cutaneous? T?cell?
lymphoma? (Marks?and?Breslow,?2007)?or?the?short?chain?fatty?acid?valproic?acid? (VPA)?for?
epilepsy?(Marson?et?al.,?2007).?
Thus,? there? is? substantial? evidence? from? the? literature? about? the? role? of? HDACs? in?
cardiovascular?and?neurological?conditions.?In?combination?with?our?mRNA?expression?data?
from?PBMCs?(Figure?5)?this?motivated?us?to?focus?on?HDAC9?as?the?most?promising?risk?gene?
within?the?7p12.1?locus.?
?
2.6???HDAC9?
HDAC9?is?mainly?expressed?in?the?brain,?heart?and?skeletal?muscle.?Global?HDAC9?deficient?
mice?were?already?generated? in?2002?by? the?group?of?Eric?N.?Olsen? to? study? the? role?of?
HDAC9? in? suppressing? cardiac? hypertrophy? (Zhang? et? al.,? 2002).? By? homologous?
recombination?with?a?targeting?vector,?exon?4?and?most?of?exon?5?of?HDAC9,?which?encode?
the?MEF2?binding?domain,?were?deleted.?Homozygous?HDAC9?/??mice?are?viable,?but? they?
develop? cardiac?hypertrophy?with? advanced? age?or? in? response? to? stress? signals? such? as?
pressure?overload?or?activated?calcineurin?(Zhang?et?al.,?2002).?This?pathological?condition?
is?caused?by?derepression?of?MEF2,?a?transcription?factor?expressed?in?myocytes?and?a?key?
regulator? of? cardiac? hypertrophy.? Interestingly,? the? MEF2?interacting? transcriptional?
repressor?(MITR),?a?HDAC9?splice?variant,?can?also?repress?MEF2?activity?despite?lacking?the?
deacetylase? domain,? indicating? that? the? catalytic? activity? is? not? essential? for? regulating?
cardiac?hypertrophy?(Zhang?et?al.,?2002).??
Several? studies? suggest? an? important? role? of?HDACs? on? Treg? function.?Administration? of?
HDAC? inhibitors? increases? the?production?and? the? function?of?FoxP3?positive?Tregs? in? the?
human?and?in?the?murine?system?(Tao?et?al.,?2007;?Akimova?et?al.,?2010).?Moreover,?HDAC9?
seems? to? regulate? FoxP3?mediated? suppression? of? Tregs.? Tao? et? al.? could? show? that? the?
number? of? FoxP3? positive? T? cells?was? increased? in? lymphoid? tissues? of?HDAC9? knockout?
mice.?HDAC9?deficient?Tregs?were?found?to?be?more?suppressive?than?wild?type?Tregs?and?
showed? increased?FoxP3?acetylation? (Tao?et?al.,?2007).? In? line?with? this,?HDAC9?deficient?
mice?were?protected? in? several?autoimmune?disease?models? like?colitis? (de?Zoeten?et?al.,?
2010;?Yan?et?al.,?2011).?
?
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In?addition?to?LVS?and?CAD,?the?HDAC9?gene?region?(7p21.1)?has?also?been?associated?with?
carotid? intima?media? thickness? and?with? carotid? plaque? presence? (Markus? et? al.,? 2013).?
Furthermore,?HDAC9?was?expressed?in?human?vascular?smooth?muscle?end?endothelial?cells?
and?HDAC9?expression?was?increased?in?human?carotid,?aortic,?and?femoral?atherosclerotic?
plaques?(Markus?et?al.,?2013).?This?represented?additional?evidence?for?a?role?of?HDAC9? in?
atherogenesis.?
? ?
?
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3???Project?design?
3.1???Aims?of?the?thesis?
The?7p21.1?locus?is?the?strongest?risk?locus?for?LVS?to?date?(Bellenguez?et?al.,?2012)?and?has?
also?been?associated?with?CAD? (Deloukas?et?al.,?2013)?and?carotid? intima?media?thickness?
(Markus? et? al.,? 2013).? This? provided? strong? evidence? for? a? role? of? this? locus? in?
atherosclerosis.?On?the?basis?of?mRNA?studies? in?human?PBMCs?and?the?described?role?of?
HDACs? in?cardiovascular?and?neurological?diseases,?HDAC9?was?selected?as?the?most? likely?
disease?causing?gene?within?the?risk?locus.?Due?to?the?significant?increase?in?HDAC9?mRNA?
levels? in?risk?allele?carriers?of?the? lead?SNP,?we?hypothesized?that?HDAC9?deficiency?could?
have? beneficial? effects.? This? was? in? line? with? published? findings? demonstrating?
neuroprotective?effects?of?HDAC? inhibitors.?The?goal?of? this?PhD?project?was? to?study? the?
consequences?of?HDAC9?deficiency?in?a?mouse?knockout?model.?First,?a?potential?role?in?the?
cardiovascular? system? was? investigated? using? an? established? mouse? model? for?
atherosclerosis.?Second,?HDAC9?deficient?mice?were?subjected?to?transient?middle?cerebral?
artery?occlusion?(MCAo)?to?analyze?effects?on?ischemic?stroke.?
?
In?particular,?this?thesis?had?the?following?objectives:?
?
A.? To?determine?the?influence?of?HDAC9?deficiency?on?atherosclerotic?plaque?formation.??
HDAC9?deficient?mice?were? crossed?with?ApoE? knockout?mice,? a?widely?used? animal?
model? for? atherosclerosis.? The? parameters? atherosclerotic? plaque? size,? immune? cell?
infiltration,?and?plaque?stages?were?analyzed.?The?results?are?presented?in?manuscripts?
1?and?2.?
?
B.? To?determine?the?influence?of?HDAC9?deficiency?on?immune?cell?homeostasis.?
Flow?cytometric?analysis?was?used?in?manuscript?2?to?study?the?distribution?of?different?
immune?cell?types?in?HDAC9?deficient?mice.??
?
C.? To?examine?the?role?of?HDAC9?deficiency?in?ischemic?stroke.?
In?manuscript?3,?HDAC9?deficient?mice?were?subjected?to?transient?MCAo.?Infarct?size,?
neurological?status?and?other?parameters?of?stroke?outcome?were?analyzed.?
?
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3.2???Experimental?strategy?
All?animal?studies?were?done?on? littermates,?using?HDAC9?heterozygous?mice?as?breeders.?
Two?different?mouse?lines?were?used.?On?the?one?hand,?the?HDAC9?deficient?mice?without?
ApoE?deficiency?were?investigated?(HDAC9?/??mice?and?their?wild?type?littermates,?HDAC9+/+?
mice)? and? on? the? other? hand,? the? HDAC9? deficient? mice? which? were? crossed? to?
atherosclerosis?prone? ApoE? deficient? mice? (HDAC9?/?ApoE?/?? mice? and? their? wild?type?
littermates?HDAC9+/+ApoE?/??mice).?
?
Objective?A?and?B:?To?determine?the?influence?of?HDAC9?deficiency?on?atherosclerotic?plaque?
formation?and?immune?cell?homeostasis??
Atherosclerotic?plaque?size?was?analyzed?in?the?aortic?root?and?the?aortic?arch?in?chow?and?
Western?type?diet? fed?HDAC9?/?ApoE?/??mice?and? their?wild?type? littermates.?First,? I?had? to?
establish? all? techniques? including? dissection,?histological? analyses,? and? flow? cytometry? in?
our? institute.?When? the?mice? reached? the? right? age,? they?were? anesthetized,? blood?was?
taken? for? the? immunological?analyses?and? the?vessels?were?perfused?with? the?vasodilator?
nitroprusside? to? achieve?maximal? vasodilation.? The? aortic? arch?with? the?main? branching?
arteries? (right?and? left?subclavian?and?common?carotid?arteries)? (Figure?7A)?was?dissected?
and?analyzed?histologically?(Figure?7B).?Additionally,?the?heart?was?taken?out?and?cut?at?the?
level?of?the?aortic?valves? (Figure?7C).?Besides?plaque?size,?plaque?stages,?and? immune?cell?
infiltration?were?analyzed.?The?distribution?of?different? immune?cell? types?was?studied?by?
flow? cytometric? analysis? (Figure? 7D)? of? the? blood? and? the? spleen.? Besides? HDAC9?ApoE?
double?knockout?mice,?HDAC9?deficient?mice?without?ApoE?deficiency?were?examined? in?
the? immunological?analyses? to?be?able? to?discriminate? the?HDAC9?effect?without?disease?
from?the?effect?in?combination?with?atherosclerosis.?
?
?
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?
Figure?7.?Work? flow? for? atherosclerotic?plaque? (Objective?A)? and? FACS? analysis? (Objective?B)? in?
HDAC9?ApoE?double?knockout?mice.?
After? anesthetizing? the?mouse,? blood? is? taken? out? by? cardiac? puncture? and? vessels? are? perfused??
with? the? vasodilator? nitroprusside.? The? spleen? is? removed,? followed? by? perfusion? with??
1%?paraformaldehyde? (PFA)? for? fixation?and?dissection?of? the?aortic?arch?and? the?heart.? In?A,? the?
main?branching?arteries?of?the?aortic?arch?are?shown.?In?B,?and?C,?examples?of?an?H&E?stained?aortic?
arch? section? and? an? Oil? Red? O? stained? aortic? valve? section? are? depicted.? In? D,? examples? of?
fluorescence?activated?cell?sorting?(FACS)?analysis?of?the?blood?and?the?spleen?are?presented.?
?
Objective?C:?To?examine?the?role?of?HDAC9?deficiency?in?ischemic?stroke.?
For? this?objective,?HDAC9?deficient?mice?without?ApoE?deficiency?were?used? to?study? the?
effect?of?HDAC9?in?stroke?without?the?involvement?of?atherosclerosis.?The?transient?middle?
cerebral?artery?occlusion?model?was?used?which? is?based?on? the?occlusion?of? the?middle?
cerebral?artery? (MCA)? for?one?hour?using?a?silicone?coated?monofilament? inserted?via? the?
internal?carotid?artery?(Figure?8).?Infarct?volume,?neurological?status,?edema?formation,?and?
other?parameters?of?stroke?outcome?were?analyzed?in?HDAC9?deficient?mice?and?their?wild?
type?littermates.?
?
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?
Figure?8.?The?middle?cerebral?artery?occlusion?(MCAo)?model?(Objective?C).?
The? left? common? and? external? carotid? arteries? are? ligated? and? a? silicone?coated?monofilament? is?
inserted? via? the? internal? carotid? artery.? After? one? hour? of? ischemia,? reperfusion? is? initiated? by?
removing? the? filament.?Anterior? cerebral?artery? (ACA);?basilar?artery? (BA);? common? carotid?artery?
(CCA);? external? carotid? artery? (ECA);? internal? carotid? artery? (ICA);?middle? cerebral? artery? (MCA);?
posterior? cerebral? artery? (PCA);? posterior? communicating? artery? (PComA);? superior? cerebellar??
artery?(SCA).?
?
?
?
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Abstract?
Background?and?Purpose:?Recent?genome?wide?association? studies? identified? the?HDAC9?
gene?region?as?a?major?risk?locus?for?large?vessel?stroke?and?coronary?artery?disease?(CAD).?
However,? the? mechanisms? linking? variants? at? this? locus? to? vascular? risk? are? poorly?
understood.? In? this? study,?we? investigated? the? candidacy? and? directionality? of?HDAC9? in?
atherosclerosis? and? analyzed? associations? between? risk? alleles? at? 7p21.1? and? plaque?
characteristics.?
Methods:?Allele?dependent?expression?of?HDAC9?was?analyzed? in?human?peripheral?blood?
mononuclear? cells? (PBMCs)? of? healthy? donors.? Effects? of? HDAC9? deficiency? on?
atherosclerotic?plaques?were?investigated?in?18??and?28?week?old?ApoE?/??mice?by?histology?
and? immunohistochemistry.? We? further? performed? detailed? plaque? phenotyping? and?
genotyping?of?rs2107595,?the?lead?SNP?in?METASTROKE,?in?carotid?endarterectomy?samples?
of?1,858?subjects?from?the?Athero?Express?Study.?
Results:?Gene?expression?studies? in?PBMCs?revealed? increased?mRNA? levels?of?HDAC9?but?
not?of?neighboring?genes?(TWIST1/FERD3L)?in?risk?allele?carriers?of?rs2107595.?Compared?to?
HDAC9+/+ApoE?/?? mice,? HDAC9?/?ApoE?/?? mice? exhibited? markedly? reduced? lesion? sizes?
throughout?atherosclerotic?aortas?and?significantly?less?advanced?lesions.?The?proportion?of?
Mac3?positive?macrophages?was?higher?in?plaques?from?HDAC9?/?ApoE?/??mice,?but?this?was?
largely?due? to?a? lower?proportion?of?advanced? lesions.?Analysis?of?human?atherosclerotic?
plaques?revealed?no?association?between?rs2107595?and?specific?plaque?characteristics.?
Conclusions:?Our? results?suggest? that?HDAC9? represents? the?disease?relevant?gene?at? the?
stroke?and?CAD?risk?locus?on?7p21.1?and?that?risk?alleles?in?this?region?mediate?their?effects?
through? elevated? HDAC9? expression.? Targeted? inhibition? of? HDAC9? might? be? a? viable?
strategy?to?prevent?atherosclerosis.?
?
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Introduction?
Stroke? and? coronary? artery? disease? (CAD)? are? among? the? most? common? causes? of?
premature?death?and? loss?of?disability?adjusted? life?years?worldwide.1,2?About?a?quarter?of?
all? strokes? are? classified? as? large? vessel? stroke? (LVS)? most? of? which? are? attributed? to?
atherosclerosis.?LVS?shares?many?risk? factors?with?CAD?and?both?conditions?have?a?strong?
heritable?component.3,4?
In? a? genome?wide? association? study? (GWAS)? we? recently? identified? the? histone??
deacetylase?9?(HDAC9)?gene?region?on?chromosome?7p21.1?as?the?strongest?risk? locus?for?
LVS? to?date.5,6?Variants?at? this? locus?were?subsequently?shown? to?be?also?associated?with?
CAD7?and?common?carotid?intima?media?thickness?(IMT)8?suggesting?that?the?effects?of?the?
7p21.1?region?are?mediated?through?atherosclerosis.??
rs2107595,?the? lead?SNP? in?METASTROKE,6? is? located?3’?to?the?HDAC9?gene.?The?next?two?
genes,?TWIST1?and?FERD3L,?reside?100?kb?downstream?to?rs2107595?whereas?other?genes?
are?more? than? 500? kb? away.? Histone? deacetylases? (HDACs)?mediate? the? acetylation? of?
histones?and?non?histone?proteins?together?with?histone?acetylases.9?The?balance?between?
acetylation? and?deacetylation?plays? a? critical? role? in? gene? expression?mechanisms?during?
embryonic?development? and?disease? states? in? later? life.10?HDAC9?has?been? implicated? in?
immune?mediated? mechanisms? and? is? expressed? in? various? cell? types? relevant? to?
atherosclerosis? including? inflammatory,?vascular?endothelial?and?smooth?muscle?cells.8,11,12?
Hence,?HDAC9?represents?a?strong?candidate?gene?for?atherosclerosis.?However,?there?are?
no?expression?data?supporting? the?candidacy?of?HDAC9?over?other?genes?at?7p21.1.?Also,?
the?relationship?between?risk?variants?in?this?region?and?plaque?morphology?remains?to?be?
determined.?We?thus? investigated?samples?from?healthy?subjects?and?patients?undergoing?
carotid? endarterectomy.13?We? further? tested? the? hypothesis? that? deficiency? of? HDAC9?
attenuates?atherosclerosis?in?mice.?
?
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Materials?and?Methods?
Allele?carrier?status?and?mRNA?expression?
DNA?and?RNA?were? isolated? from?peripheral?blood?mononuclear?cells? (PBMCs)?of?healthy?
donors? (43?male,?34? female,?age?65.3±20.8? [mean±SD]?years).?Carrier?status?at?rs2107595?
was? determined? by? direct? sequencing.? RNA? was? isolated? using? PAXgene? Blood? RNA? Kit?
(PreAnalytiX?GmbH)?according?to?the?manufacturer`s?protocol.?For?each?sample,?800?ng?of?
DNase?treated? RNA? were? converted? into? cDNA? (Omniscript? RT? Kit,? Qiagen)? using? Oligo?
dT(15)? primer.? For? quantitative? real?time? PCR? cDNAs? were? diluted? with? water? 1:9? and?
analyzed? using? TaqMan? Gene? Expression? Assays? (ABI? Bioscience)? for? human? HDAC9,?
TWIST1,?FERD3L?and?RPLP0.?Measurements?were?performed?in?triplicates.?Results?for?target?
genes?were?normalized?to?the?reference?gene?RPLP0?and?to?a?calibrator?sample.?All?subjects?
provided?written?informed?consent.??
?
Atherosclerotic?plaque?analysis?in?mice?
All? animal?protocols?were? approved?by? the? government?of?Upper?Bavaria.?HDAC9?/??mice?
from? E.?Olson14?were? provided? by? Laurent? Schaeffer? (Université? Lyon)? and?were? crossed?
with?ApoE?deficient?mice?(The?Jackson?Laboratory)?to?generate?HDAC9?/?ApoE?/??mice.?Mice?
had?ad?libitum?access?to?food?and?water?and?were?housed?under?a?12?h?light?dark?cycle.?All?
experiments?were?done?on?male?littermates?fed?a?standard?chow?diet?to?sensitively?capture?
the? effect? of? HDAC9? on? spontaneous? rather? than? aggravated? and? accelerated?
atherosclerosis? induced? by? western?type? diet.? Animals? were? sacrificed? at? age? 18? or?
28?weeks? (n? =? 8?13? for? each? genotype? and? time? point)?by? an?overdose?of? ketamine? and?
xylazin.?Blood?was?obtained?by?cardiac?puncture? from? the? right?ventricle?and?plasma?was?
used? for? cholesterol? measurements? using? a? colorimetric? assay? (Cayman? Chemical?
Company).?The?arterial? tree?was?perfused? through? the? left?ventricle?with?6?ml?phosphate?
buffered?saline?(PBS,?containing?sodium?nitroprusside?(1?mg/ml,?Sigma?Aldrich))?to?achieve?
vasodilation?and?10?ml?1%?paraformaldehyde?(PFA)?for?tissue?fixation.?The?aortic?arch?and?
its?main?branch?points?were?removed?and?fixed?for?24?h?in?a?1%?PFA?solution.??
To?evaluate?atherosclerotic? lesion?size,?a?total?of?8?cryosections?(8??m)?extending?cranially?
through?the?aortic?valves?at?104??m? intervals?were?cut.?Lesion?area?per?cross?section?and?
relative?area?of?lesions?were?quantified.?Relative?lesion?area?was?calculated?for?each?section?
as?R%?=?(100?×?L/A),?where?L?is?lesion?area?and?A?is?area?inside?the?external?elastic?lamina.?
?
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The?relative?lesion?area?was?expressed?as?the?mean?of?four?consecutive?sections?(104?μm???
416?μm)?per?mouse.?We? further?measured?plaque?sizes?of? the?aortic?arch?of?28?week?old?
mice.?The?aortic?arch?was?embedded? in?paraffin?and?cut? into? consecutive?4?μm? sections.?
Four? sections?at?20?μm? intervals?were? chosen? for?plaque?analysis.? Sections?were? stained?
with?hematoxylin?and?eosin?(H&E)?and? lesion?areas?of?the?total?aorta?as?well?as? individual?
lesions?at?the?main?branch?points?and?the?curvature?were?measured?by?AxioVision?Software?
(Zeiss,?Germany).? The? number? of? plaques? per? arch?was? counted.? Atherosclerotic? lesions?
were? classified? as? initial? or? advanced? using? the? Virmani? classification.15? The? number? of?
nuclei?and?the?acellular?core?area?per?plaque?in?the?brachiocephalic?artery?were?quantified.??
Immunohistochemistry?was?performed?on?paraffin?sections?of?the?aortic?arch?(n?=?8?13?for?
each?phenotype).?A?Mac3?monoclonal?antibody? (1:100?dilution,?M3/84,?BD?Bioscience)? to?
detect?macrophages?and?an?isotype?matched?control?antibody?were?used.?Antibodies?were?
titrated? to? optimal? performance? and? applied? to? PFA?fixed? paraffin? sections? of? the? aortic?
arch? followed? by? detection? using? an? ABC? peroxidase? kit? and? DAB? substrate? (both? from?
Vector?Laboratories).?The?stainings?were?quantified?by?ImageJ?Software?and?the?number?of?
Mac3?positive? cells? per? lesion? was? divided? by? the? total? number? of? cells? per? lesion,? as?
determined?by?number?of?nuclei?per?lesion.?
All? experiments? and? data? analysis? were? performed? under? blinded? conditions? for? the?
genotype.?
?
rs2107595?and?human?atherosclerotic?plaques?
Human?carotid?atherosclerotic?plaques? (N=1,858)?were?obtained? from? the?Athero?Express?
Study,? an? ongoing,? longitudinal,? multi?center? study? collecting? carotid? atherosclerotic?
plaques? from? patients? with? significant? (>70%)? stenosis? who? undergo? carotid?
endarterectomy.13,16?The?medical?ethics? committee?of? the?participating? centers?approved?
the?study?and?written?informed?consent?was?obtained?from?all?patients.??
Immunohistochemical?plaque?phenotyping?was?performed?as?described?elsewhere.13,16? In?
brief,?carotid?plaques?were?divided?into?segments?of?5?mm?thickness.?The?culprit?lesion?was?
defined? and? used? for? immunohistochemical? staining.? Calcification? (hematoxylin?&? eosin,?
H&E)?and?collagen?content?(picrosirius?red)?were?semi?quantitatively?defined?as?no?or?minor?
vs.?moderate/heavy?staining?as?previously?described.13,16?Atheroma?size?was?defined?as?less?
than? or?more? than? 10%? fat? content? (H&E? and? picrosirius? red).?We? quantitatively? scored?
?
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macrophages?(CD68)?and?smooth?muscle?cells?(??actin)?as?percentage?plaque?area.?We?also?
determined? the? presence? of? intraplaque? hemorrhage? (H&E)? and? counted? the? number? of?
vessel?per?3?4?hotspots?(CD34).?
Genotyping?was?done?in?two?batches?using?Affymetrix?arrays.?rs2107595?was?imputed?using?
phased? data? from?HapMap? 2? (release? 22,? b36)? as? a? reference.?Quality? control? (QC)?was?
performed? according? to? standard?procedures.?Detailed?description?of? genotyping,?quality?
control?and?imputation?is?provided?in?the?online?only?Data?Supplement.?
?
Statistical?analysis?
For? the?human?mRNA?expression?data?and? the?murine?plaque?analysis,?GraphPad?Prism?5?
(GraphPad? Software)? and? SigmaPlot? 12.5? (Systat? Software? Inc.)?were? used? for? statistical?
analysis.? Groupwise? comparisons? (n>2)?were? performed? using? a? nonparametric? Kruskal?
Wallis?test?followed?by?a?Mann?Whitney?test.?Pairwise?comparisons?were?performed?using?a?
Mann?Whitney?test.?Differences?were?considered?statistically?significant?at?P<0.05.?Data?are?
expressed?as?mean±SEM.?
For?statistical?analysis?of?the?Athero?Express?data?quantitative?histological?phenotypes?were?
normalized? through? natural? log? (LN)? transformation;? outliers? deviating?more? than? ±3? SD?
from? the?LN?transformed?mean?were? removed.?Genetic?analyses?were? corrected? for?age,?
sex,?10?principal?components,?year?of?surgery?and?a?dummy?variable?representing?the?two?
genotyping? batches,? assuming? an? additive? genetic?model.? Linear? and? logistic? regression?
models?were?used?for?quantitative?and?binary?phenotypes,?respectively.?IBM?SPSS?Statistics?
version?20?(release?20.0.0,?IBM?Corp.,?Armonk,?NY,?USA)?was?used?for?statistical?analyses?of?
baseline?characteristics.?PLINK?v1.7?and?Golden?Helix?SNP?&?Variation?Suite?v8.1.5?(Golden?
Helix,? Inc.,?Bozeman,?MT,?USA)?were? used? for? genetic? analyses.?Our?power? to?detect? an?
association?between?rs2107595?and?individual?plaque?phenotypes?at?a?significance?level?of?
0.05?[0.005]?with?a?sample?size?of?1,400,?an?effect?size?of?0.182?and?a?minor?allele?frequency?
of?20%?was?>90%?[>75%]?for?quantitative?phenotypes.?For?binary?phenotypes?our?power?to?
detect?an?OR?of?1.20?(corresponding?to?an?effect?size?of?0.182)?was?between?20%?[4%]?(for?
collagen)? and? 54%? [23%]? (for? intraplaque? hemorrhage).? To? account? for? testing?multiple?
phenotypes?the?level?of?statistical?significance?was?set?at?0.005.?
? ?
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Results?
rs2107595?risk?allele?carriers?show?increased?HDAC9?mRNA?expression?in?PBMCs?
rs2107595,? the? lead? SNP? in?METASTROKE,6? is? situated? in? the? intergenic? region? between?
HDAC9? and? TWIST1/FERD3L? and? co?localizes? with? both? Deoxyribonuclease? I? (DNase? I)?
hypersensitivity? clusters? and? histone? modification? hotspots? (UCSC? Genome? Browser,17?
genome?build?hg18,?Figure?1A),? suggesting?a?possible? involvement?of? this?variant? in?gene?
regulation.??
?
?
Figure? 1.? HDAC9? mRNA? levels? are? significantly? elevated? in? risk? allele? carriers? of? the? lead? SNP?
(rs2107595)? found? to? be? associated?with? large? vessel? stroke.? A,? Regional? association? plot? of? the?
HDAC9? gene? region? showing? association? signals? around? rs2107595? for? LVS? in? the?METASTROKE?
dataset.6?Top,?SNPs?are?colored?based?on?their?correlation?with?rs2107595,?which?has?the?smallest??
P?value? in? the? region.?Bottom,?DNase? I?hypersensitivity?clusters?and?histone?modification?hotspots?
(H3K4Me1,? H3K27Ac).? B,? Relative? mRNA? expression? of? HDAC9? in? human? PBMCs? for? different?
genotypes? of? rs2107595.? HDAC9? mRNA? levels? are? significantly? elevated? in? homozygous? and?
heterozygous?carriers?of?the?risk?allele? (A)?with?a?gene?dosage?effect? (GG?n=51,?GA?n=22,?AA?n=4).?
Results? represent?mean±SEM.?*P<0.05,?**P<0.01? (Kruskal?Wallis? test?P=0.003,? followed?by?Mann?
Whitney?test).?
?
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We?thus?measured?mRNA?expression?levels?of?HDAC9,?TWIST1?and?FERD3L?in?PBMCs?from?
healthy? donors.? HDAC9? mRNA? levels? were? significantly? increased? in? homozygous? and?
heterozygous?carriers?of?the?risk?allele?(rs2107595A)?with?a?gene?dosage?effect?(Figure?1B).?
In?contrast,?mRNA? levels?of?the?adjacent?genes?TWIST1?and?FERD3L?did?not?correlate?with?
allele?carrier?status?at?rs2107595?(Figure?I? in?the?online?only?Data?Supplement),?suggesting?
that?variants?at?this? locus?regulate?HDAC9?expression?and?that?the?effects?of?this? locus?on?
stroke?risk?might?be?mediated?through?elevated?HDAC9?expression.?
?
HDAC9?deficiency?reduces?atherosclerotic?lesion?size?in?mice?
To? test? the?hypothesis? that?HDAC9?deficiency? attenuates? atherogenesis? and? to? refine? its?
influence?on?plaque?composition,?we?crossed?HDAC9?/??mice?with?ApoE?/??mice?and?fed?them?
a?normal?chow?diet.?HDAC9?/?ApoE?/??mice?showed?a?significant?reduction?of?atherosclerotic?
lesion?size?at?both?18?weeks?and?28?weeks?of?age?in?aortic?valve?sections?(Figure?2A?and?2B)?
as?well?as?in?aortic?arch?sections?(Figure?2C?and?2D).??
A? significant? reduction? in? plaque? area?was? also? found? in? the? brachiocephalic? artery? and?
aortic?curvature?(Figure?IIA?in?the?online?only?Data?Supplement).?The?number?of?plaques?in?
the?aortic?arch?was?significantly?reduced?(Figure?IIB?in?the?online?only?Data?Supplement).?
?
?
?
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Figure? 2.? HDAC9? deficiency? reduces? atherosclerotic? plaque? size? in? ApoE? deficient? mice.??
A,? Representative? images? showing? Oil?Red? O?? and? hematoxylin? stained? cryosections? from? the?
proximal?aorta?of?HDAC9+/+ApoE?/??and?HDAC9?/?ApoE?/??mice?at?18?and?28?weeks?of?age.?Scale?bars:?
250?μm.?B,?Absolute?plaque?areas?at?different?distances?from?the?aortic?valves?of?18?week?old?mice?
(top)?and?relative?plaque?area?(in?relation?to?the?area?inside?of?the?external?elastic?lamina)?(bottom).?
C,?Representative?images?showing?dissected?aortic?arches?of?28?week?old?mice.?D,?Total?plaque?area?
in?the?aortic?arch?of?28?week?old?mice.?Values?represent?mean?plaque?area?for?each?mouse;?n?=?8?13?
for?each?genotype?and?time?point;?*P<0.05;?**P<0.01?vs.?wildtype?(Mann?Whitney?test).?
?
Next,? we? categorized? atherosclerotic? lesion? stage? using? the? Virmani? classification.15?We?
distinguished?intimal?xanthomas?consisting?mainly?of?foam?cells?from?advanced?atheromas?
characterized?by? fibrous?cap?and?acellular?areas.? In?brachiocephalic?artery?plaques? (Figure?
3A?and?3B)?only?2?out?of?8?HDAC9?/?ApoE?/??mice?showed?acellular?areas?compared?to?12?out?
of?13?HDAC9+/+ApoE?/??(P<0.01)?(Figure?3C).?The?reduction?in?acellular?cores?corresponded?to?
the?increased?number?of?nuclei?per?lesion?area?in?HDAC9?/?ApoE?/??mice?(Figure?3D).?
?
?
?
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Figure? 3.?HDAC9? deficiency? affects? composition? of? atherosclerotic? plaques? in? the? brachiocephalic?
artery? (BCA)?of?28?week?old?mice.?A,?Overview?of?aortic?arch.?Orange?rectangle? indicates?region?of?
interest?for?plaque?analysis?in?the?BCA.?B,?Representative?images?of?H&E?stained?plaques?are?shown.?
C,?Acellular?core?per? lesion?area? in?the?BCA.?D,?Nuclei?per? lesion?area? in?the?BCA.?n?=?8?13?for?each?
genotype;? scale? bars:? 100? ?m;? *P<0.05;? **P<0.01? vs.? wildtype? (Mann?Whitney? test);? BCA?
brachiocephalic?artery,?CCA?common?carotid?artery,?SCA?subclavian?artery,?Curv.?aortic?curvature.?
?
Analysis? of? the? entire? aorta? likewise? revealed? a? lower? proportion? of? advanced? lesions? in?
HDAC9?deficient? mice? (HDAC9+/+ApoE?/?:? 43±7%;? HDAC9?/?ApoE?/?:? 12±6%;? [mean±SEM];?
Figure? 4A).? In? addition,? immunostaining? for? Mac3? showed? a? higher? proportion? of?
macrophages? in? plaques? from? HDAC9?/?ApoE?/??mice? (Figure? 4B? and? 4C).? However,? after?
exclusion? of? advanced? lesions? no? difference? of?Mac3? infiltration? was? observed.? Plasma?
cholesterol?levels?measured?at?18?and?28?weeks?did?not?differ?between?HDAC9?/?ApoE?/??and?
HDAC9+/+ApoE?/??mice?(Figure?IIC?in?the?online?only?Data?Supplement).?
?
?
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Figure?4.?HDAC9?deficiency?affects?stages?and?composition?of?atherosclerotic?plaques?in?the?aorta?of?
28?week?old?mice.?A,?Classification?of?aortic?arch?lesions?according?to?their?stage?of?atherosclerosis.?
Initial?plaques? (intimal?xanthomas?and?pathological? intimal? thickenings);?advanced?plaques? (fibrous?
cap?atheromas).?B,?Immunostaining?for?Mac3?and?quantification?of?Mac3?positive?cells?in?all?plaques?
in?the?total?aorta?and?in?initial?plaques?only?(following?exclusion?of?advanced?atheromas).?n?=?8?13?for?
each?genotype;?scale?bars:?100??m;?*P<0.05;?**P<0.01?vs.?wildtype?(Mann?Whitney?test).?
?
rs2107595?has?no?discernable?effect?on?plaque?morphology?in?humans?
To? explore? potential? associations? between? risk? alleles? at? HDAC9? and? specific? advanced?
plaque? characteristics? we? genotyped? 1,858? subjects? with? available? detailed? plaque?
phenotyping? from? Athero?Express.? 1,439? subjects? passed? quality? control.? Their?
demographic? and? clinical? characteristics? are?presented? in? Table? I? in? the?online?only?Data?
Supplement.?There?was?no?significant?association?between? rs2107595?and?specific?plaque?
characteristics? in? the?overall?sample? (Table?1)?or?when?analysis?was? restricted? to?patients?
with?asymptomatic?plaques,?symptomatic?plaques?or?stroke?(Table?II?in?the?online?only?Data?
Supplement).?
?
Table?1.?Association?of?rs2107595?with?plaque?phenotypes?in?the?Athero?Express?Study?(N=1,439).?
?
MAF? OR? ß? 95%?CI? SEM? P? Phenotype? N?
0.800? 1.129? NA? 0.93?1.38? NA? 0.215? calcification? 705/700?
0.800? 0.877? NA? 0.69?1.12? NA? 0.284? collagen? 1129/277?
0.800? 1.164? NA? 0.94?1.44? NA? 0.162? atheroma?size? 1018/389?
0.800? 1.211? NA? 0.99?1.48? NA? 0.058? intraplaque?hemorrhage? 849/557?
0.800? NA? 0.120? NA? 0.089? 0.176? macrophages? 1403?
0.800? NA? ?0.071? NA? 0.064? 0.261? smooth?muscle?cells? 1375?
0.797? NA? ?0.036? NA? 0.037? 0.329? vessel?density? 1216?
?
MAF:?major?allele?frequency;?odds?ratios?(OR)?and?effect?sizes?(ß)?are?relative?to?the?major?allele?(G)?
on?genome?build?36;?P?values?are?two?sided.?Phenotype:?calcification?and?collagen?are?coded?as?no?
or? minor? vs.? moderate? heavy? staining,? atheroma? size? is? coded? as? <10%? vs.? >10%? fat? content,?
intraplaque?hemorrhage?as?no?vs.?yes,?macrophages?and?smooth?muscle?cells?are?natural? log? (LN)?
transformed?percentages?of?plaques,?and?vessel?density? is?the?LN?transformed?average? intraplaque?
vessel? density? per? 3?4? hotspots.?N? is? the? number? of? patients? analyzed? for? the? respective? plaque?
phenotype.?SEM:?standard?error?of?the?mean;?NA:?not?applicable.?
?
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Discussion?
This?study?provides?converging?evidence?that?HDAC9?represents?the?disease?relevant?gene?
at?the?stroke?and?CAD?risk? locus?on?7p21.1?and?that?risk?alleles?at?this? locus?mediate?their?
effects?through?increased?HDAC9?expression.?
Our? finding?of?elevated?HDAC9?mRNA?expression? in? risk?allele? carriers?of? rs2107595,? the?
lead?SNP?in?METASTROKE,?is?consistent?with?recent?data?from?the?ENCODE?project?showing?
that? the? majority? of? disease?associated? variants? are? located? in? regulatory? regions? and?
control? genes? within? a? distance? of? ±500? kb.? rs2107595? resides? inside? a? DNase? I?
hypersensitivity?cluster?and?histone?modification?hotspot.? In?fact,?rs2107595A? is?predicted?
to?disrupt?a?consensus?sequence?for?an?E2F3?binding?site?(TRANSFAC?database,18?data?not?
shown),?a? transcription? factor? forming?a? repressor?complex?with?Rb?proteins,? thus? raising?
the? possibility? that? this? variant? is? implicated? in? gene? regulation.? However,? the? exact?
mechanism?by?which?genetic?variation?at?this?locus?regulates?HDAC9?expression?remains?to?
be? determined.? TWIST1? and? FERD3L,? the? only? other? genes? nearby,? exhibited? no? allele?
dependent?mRNA? expression? and? are? thus? less? likely? to? be? implicated? in? locus?specific?
effects.?However,?because?our?expression?analyses?were? restricted? to?PBMCs,?we? cannot?
exclude?regulatory?effects?in?other?cell?types.?
Complementing? our? expression? data,? we? found? deficiency? of? HDAC9? to? attenuate?
atherogenesis? in?ApoE?/??mice.?The? reduction?of?atherosclerotic? lesion? size? reaching?up? to?
45%?in?28?week?old?animals,?was?present?throughout?all?segments?of?the?aortic?arch?(aortic?
valves,? curvature,? branching? arteries)? and? already? significant? in? 18?week?old? animals.?
Staging?of?lesions?further?revealed?that?HDAC9?/?ApoE?/??mice?had?significantly?less?advanced?
lesions?compared?to?HDAC9+/+ApoE?/??mice.?Together,?these?findings?demonstrate?a?strong?
effect? of? HDAC9? expression? on? atherogenesis.? The? higher? proportion? of?Mac3?positive?
macrophages? in?plaques? from?HDAC9?/?ApoE?/??mice? likely? reflects? the? lower?proportion?of?
acellular? areas? that? are? typical? for? advanced? lesions? as? there?was?no?difference?of?Mac3?
infiltration?when?we? restricted? our? analyses? to? intimal? xanthomas.?Hence,?we? found? no?
obvious?influence?of?HDAC9?deficiency?on?plaque?morphology.??
In?accordance?with?our?findings?in?mice,?no?significant?association?between?rs2107595?and?
specific?plaque?characteristics?was?found?in?human?carotid?plaques?from?the?Athero?Express?
Study.? Importantly,?our?power? to?detect? an? association?with?macrophage? count,? smooth?
muscle?cell?count,?and?vessel?density?was?over?75%.?Hence,?we?are?confident?that?we?would?
?
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have?captured?any?prominent?effect?on?these?plaque?phenotypes.?However,?our?power?to?
detect?associations?with?binary?plaque?phenotypes?was? limited.?Thus,?we? cannot?exclude?
allele?specific? effects? on? collagen? content,? atheroma? size,? calcification,? and? intraplaque?
hemorrhage.?Interestingly,?a?recent?meta?analysis?of?population?based?cohorts?revealed?an?
association?of?rs2107595?with?carotid?IMT?measured?by?ultrasound.8?Taken?together,?these?
data?suggest?that?HDAC9?expression?promotes?early?atherogenesis?rather?than?accelerating?
progression? to? vulnerable?plaques.?However,?we? cannot?exclude? skewing?of?macrophage?
polarization?from?M1?to?M2?phenotype?as?previously?reported.19?
The?precise?mechanisms?by?which?elevated?HDAC9?expression?promotes?atherogenesis?and?
vascular? risk? remain? to? be? determined.?A? recent? study? found? that? targeted? depletion? of?
HDAC9?in?bone?marrow?cells?attenuates?atherogenesis?in?LDLr?/??mice.19?HDAC9?was?further?
shown? to? repress? cholesterol? efflux? in?macrophages.? However,?whether? the? changes? in?
macrophages?give? rise? to?atherosclerotic? lesion? formation? remains? speculative.?Given? the?
widespread?expression?of?HDAC9? in?multiple? cell? types? there?are? several?mechanisms?by?
which?elevated?HDAC9?expression?could?promote?atherosclerosis.?For?example,?HDAC9?has?
been? shown? to? inhibit? FOXP3? expression? and? the? function? of? regulatory? T? cells,20?which?
protect?against?atherosclerosis.21,22?
Our?findings?imply?that?targeting?HDAC9?may?be?a?viable?strategy?to?prevent?atherosclerosis?
progression.? Broad?spectrum? HDAC? inhibitors? have? multiple? off?target? effects? and?
exacerbate? atherosclerosis.23? Selective? inhibitors? of? class? IIa? HDACs? have? recently? been?
developed?but?not? yet? sufficiently? tested? in? vivo.24?Given? the?pleiotropic? role?of? class? IIa?
HDACs?developing?inhibitors?with?selectivity?for?HDAC9?seems?the?most?promising?approach?
to?specifically?target?atherosclerotic?lesion?formation.?
In?conclusion,?this?study?provides?mechanistic? insights?how?genetic?variation? in?the?HDAC9?
gene?region,?a?major?risk? locus?for?LVS?and?CAD,?promotes?atherosclerosis.?Moreover,?our?
findings? suggest? that? selective? pharmacological? inhibition? of?HDAC9?may? be? an? effective?
strategy?to?prevent?atherosclerosis?and?its?clinical?manifestations.?
?
?
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Supplemental?Methods?
?
Human?carotid?plaque?studies?
?
Genotyping?
We? performed? two? genome?wide? association? (GWA)? experiments? in? 1,858? consecutive?
patients? from? Athero?Express? Study.? DNA? was? extracted? from? whole? blood? or? carotid?
plaques? following? standardized? protocols.? The? first? experiment? was? performed? in? the?
Athero?Express? Genomics? Study? 1? (AEGS1;? n=836? patients? recruited? between? 2002? and?
2007)?and?was?carried?out?by?AROS?Applied?Biotechnology?(Denmark)?under?study?number?
A318?using?the?Affymetrix?Genome?Wide?Human?SNP?Array?5.0?(SNP5)?chip?(Affymetrix?Inc.,?
Santa? Clara,? CA,? USA).? The? second? experiment? was? performed? in? the? Athero?Express?
Genomics? Study? 2? (AEGS2;? n=1,022? patients? recruited? between? 2002? and? 2013).? These?
samples? were? genotyped? at? the? Genomic? Analysis? Center,? Helmholtz? Center? Munich?
(Germany)?using?the?Affymetrix?Axiom?GW?CEU?1?Array?(AxM).?
?
Genotyping?quality?control?and?imputation?
Quality? control? (QC)?was? performed? according? to? standard? procedures.?Genotype? calling?
was?conducted?using?the?standard?settings?of?Affymetrix?Genotyping?Console?4.0?Software?
(GCOS4)?and? the?proper?algorithm? for?each? chip? (BRLMM?P? for?SNP5?and?Axiom?GT1? for?
AxM,?respectively).?Subsequent?QC?included?the?following?steps:?We?first?excluded?samples?
with? low? average? genotype? calling? and? gender? discrepancies? (compared? to? clinical? data)?
based?on?GCOS4?metrics.?Next,?data?were?filtered?on?1)?individual?(sample)?call?rate?>?97%,?
2)?SNP?call?rate?>?97%,?3)?minor?allele?frequencies?>?3%,?4)?average?heterozygosity?rate?±?3.0?
SD,?5)?relatedness?(pi?hat?>?0.20),?6)?Hardy–Weinberg?Equilibrium?(HWE?P?value?<?1.0x10?6),?
and?7)?population?stratification?(based?on?HapMap?2,?release?22,?b36)?by?excluding?samples?
deviating?more?than?6?standard?deviations?from?the?average?in?5?iterations?during?principal?
component?analysis?and?by?visual? inspection.?All?subjects?were?of?self?reported?European?
ancestry,?which?was?confirmed? through?PCA.?After?QC?657?and?869? samples? from?AEGS1?
and?AEGS2?respectively,?were?available?for?imputation.?A?total?of?403,789?markers?in?AEGS1?
and? 535,983? in? AEGS2? were? included? before? imputation.? Autosomal?missing? genotypes?
?
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were?imputed?in?both?datasets?using?phased?data?from?the?HapMap?2?project1?(release?22,?
b36)?and?BEAGLE2?v3.3.2?(31?October?2011).?
?
Statistical?analysis?
For? statistical? analysis? quantitative? histological? phenotypes? were? normalized? through?
natural? log? (LN)? transformation;? outliers? deviating? more? than? ±3? SD? from? the? LN?
transformed? mean? were? removed.? Genetic? analyses? were? corrected? for? age,? sex,??
10? principal? components,? year? of? surgery? and? a? dummy? variable? representing? the? two?
genotyping? batches,? assuming? an? additive? genetic?model.? Linear? and? logistic? regression?
models?were?used?for?quantitative?and?binary?phenotypes,?respectively.?IBM?SPSS?Statistics?
version?20?(release?20.0.0,?IBM?Corp.,?Armonk,?NY,?USA)?was?used?for?statistical?analyses?of?
baseline?characteristics.?PLINK3?v1.7?and?Golden?Helix?SNP?&?Variation?Suite?v8.1.5?(Golden?
Helix,? Inc.,?Bozeman,?MT,?USA)?were? used? for? genetic? analyses.?Our?power? to?detect? an?
association?between?rs2107595?and?individual?plaque?phenotypes?at?a?significance?level?of?
0.05?[0.005]?with?a?sample?size?of?1,400,?an?effect?size?of?0.182?and?a?minor?allele?frequency?
of?20%?was?>90%?[>75%]?for?quantitative?phenotypes.?For?binary?phenotypes?our?power?to?
detect?an?OR?of?1.20?(corresponding?to?an?effect?size?of?0.182)?was?between?20%?[4%]?(for?
collagen)? and? 54%? [23%]? (for? intraplaque? hemorrhage).? To? account? for? testing?multiple?
phenotypes?the?level?of?statistical?significance?was?set?at?0.005.?
? ?
?
?
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Supplemental?Tables?
?
Table?I.?Demographic?characteristics?of?the?Athero?Express?Study.?
?
Characteristic?
Total?sample,?N? 1,439?
Age?in?years,?mean?(SD)? 68.31?(9.31)?
Sex,?male,?%? 67.89?
Mean?arterial?pressure?(SD),?mmHg?? 106.71?(15.86)?
Total?cholesterol?(SD),?mmol/l? 4.72?(1.24)?
Smoking,?%? 34.26?
Diabetes?mellitus,?%? 22.79?
BMI?(SD),?kg/m2? 26.29?(3.86)?
Time?since?last?cerebrovascular?event,?median?(IQR),?days? 43.50?(18?92)?
Index?event,?%?
Asymptomatic? 28.42?
Symptomatic? 70.95?
Transient?ischemic?attack? 44.34?
Stroke? 26.62?
SD:?standard?deviation.?IQR:?interquartile?range.?
?
?
? ?
?
?
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Table? II.?Association?of? rs2107595?with?plaque?phenotypes? in?patient? subgroups? from? the?Athero?
Express?Study.?
?
MAF? OR? 95%?CI? P? Phenotype? N?
asymptomatic?(N=409)?
0.800? 0.786? 0.53?1.16? 0.229? calcification? 234/168?
0.799? 1.024? 0.63?1.67? 0.926? collagen? 339/63?
0.799? 1.146? 0.78?1.69? 0.496? atheroma?size?(10%)? 268/135?
0.799? 1.698? 1.16?2.49? 0.007? intraplaque?hemorrhage? 229/173?
0.799? 1.347? 0.97?1.88? 0.079? macrophages? 399?
0.801? 0.868? 0.70?1.07? 0.188? smooth?muscle?cells? 397?
0.791? 1.015? 0.89?1.16? 0.825? vessel?density? 354?
?
symptomatic?(N=1,021)?
0.801? 1.230? 0.98?1.55? 0.077? calcification? 469/525?
0.802? 0.768? 0.58?1.02? 0.072? collagen? 787/208?
0.802? 1.169? 0.90?1.51? 0.234? atheroma?size?(10%)? 742/253?
0.802? 1.082? 0.85?1.37? 0.520? intraplaque?hemorrhage? 616/379?
0.802? 1.078? 0.87?1.33? 0.482? macrophages? 995?
0.801? 0.947? 0.81?1.10? 0.487? smooth?muscle?cells? 969?
0.801? 0.954? 0.87?1.04? 0.297? vessel?density? 858?
?
stroke?(N=383)?
0.800? 1.404? 0.96?2.05? 0.081? calcification? 175/198?
0.800? 0.720? 0.44?1.19? 0.201? collagen? 306/67?
0.800? 1.159? 0.76?1.78? 0.499? atheroma?size?(10%)? 276/97?
0.801? 0.809? 0.54?1.21? 0.307? intraplaque?hemorrhage? 232/140?
0.800? 1.178? 0.85?1.63? 0.324? macrophages? 374?
0.802? 1.048? 0.83?1.32? 0.693? smooth?muscle?cells? 364?
0.809? 0.954? 0.82?1.12? 0.559? vessel?density? 317?
?
MAF:?major?allele?frequency;?odds?ratios? (OR)?are?relative?to?the?major?allele? (G)?on?genome?build?
36;? P?values? are? two?sided.? Phenotype:? calcification? and? collagen? are? coded? as? no? or?minor? vs.?
moderate? heavy? staining,? atheroma? size? is? coded? as? <10%? vs.? >10%? fat? content,? intraplaque?
hemorrhage? (IPH)? as? no? vs.? yes,? macrophages? and? smooth? muscle? cells? are? natural? log? (LN)?
transformed?percentages?of?plaques,?and?vessel?density? is?the?LN?transformed?average? intraplaque?
vessel? density? per? 3?4? hotspots.?N? is? the? number? of? patients? analyzed? for? the? respective? plaque?
phenotype.? Asymptomatic:? includes? patients? with? significant? stenosis? (>50%)? or? ocular? events?
(including?amaurosis?fugax?or?retinal? infarction)?but?no?history?of?transient? ischemic?attack?(TIA)?or?
stroke?prior?to?carotid?endarterectomy?(CEA).?Symptomatic:?includes?patients?with?a?history?of?TIA?or?
stroke?prior?to?CEA.? ?
?
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Supplemental?Figures?
?
?
?
Figure? I.?Relative?mRNA?expression?of?HDAC9,?TWIST1?and?FERD3L? in?human?PBMCs? for?different?
genotypes? of? rs2107595.? HDAC9? mRNA? levels? are? significantly? elevated? in? homozygous? and?
heterozygous?carriers?of?the?risk?allele?(A)?with?a?gene?dosage?effect?(GG?n=51,?GA?n=22,?AA?n=4).?For?
TWIST1?(GG?n=23,?GA?n=3,?AA?n=4)?and?FERD3L?(GG?n=23,?GA?n=3,?AA?n=1)?no?correlation?with?allele?
carrier? status? was? found.? Results? represent? mean±SEM.? *P<0.05,? **P<0.01? (Kruskal?Wallis? test?
followed?by?Mann?Whitney?test).?
?
?
?
Figure?II.?A,?Plaque?area?of?the?main?branches?and?the?curvature?of?the?aorta? in?28?week?old?mice.??
B,? Number? of? plaques? per? aortic? arch.? C,? Plasma? cholesterol? in? 18? and? 28?week?old?male?mice.?
Results? represent?mean±SEM.?n? =? 8?13? for? each? genotype? and? time?point;? *P<0.05;? **P<0.01? vs.?
wildtype? (Mann?Whitney? test).? BCA? brachiocephalic? artery,? CCA? common? carotid? artery,??
SCA?subclavian?artery.?
?
?
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Abstract?
Cardiovascular? diseases? including? stroke? and? ischemic? heart? disease? belong? to? the?most?
common? causes? for?mortality?worldwide.?Atherosclerosis? is? the?underlying?pathology? for?
these? diseases.?We? could? recently? demonstrate? that? deficiency? of? histone? deacetylase? 9?
(HDAC9),?which?was? identified?as?a? risk?gene? for? large? vessel? stroke?and? coronary?artery?
disease,?is?atheroprotective?in?a?mouse?atherosclerosis?model.?The?aim?of?the?current?study?
was?to? investigate?the?effect?of?HDAC9?deficiency?on?atherosclerotic?plaque?size,? immune?
cell? infiltration? and? immune? cell? distribution? in?mice?using? different?dietary? settings.?We?
could? show? that? HDAC9? deficiency? mainly? affects? early? atherogenesis? by? delaying? the?
development? of? progressed? atherosclerotic? lesions.? Using? a? Western?type? diet,? where?
lesions?are?in?a?more?advanced?stage,?atherosclerotic?lesion?size?was?comparable?between?
HDAC9+/+ApoE?/?? and? HDAC9?/?ApoE?/?? mice.? Flow? cytometry? analysis? revealed? a? shift? in?
monocyte? populations? from? classical,? inflammatory? monocytes? to? resident? monocytes.?
Furthermore,? frequencies? of? monocytes/macrophages? were? reduced? in? the? spleen? of?
HDAC9?deficient?mice.? In?addition,?T? cell?analysis? revealed? that? chow? fed?HDAC9?/?ApoE?/??
mice?harbored?significantly? less?effector?memory?T?cells?suggesting?a?decreased?activation?
and?mobilization?of?T?cells?in?HDAC9?deficient?mice.?These?findings?support?our?hypothesis?
that? both? innate? as? well? as? adaptive? immune? responses? play? an? important? role? in? the?
atheroprotective?effect?mediated?by?HDAC9?deficiency.?Inhibition?of?HDAC9?seems?to?be?a?
promising? therapeutic? strategy? for? the? prevention? of? atherosclerosis? by?modulating? the?
immune?system.?
?
?
? ?
?
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Introduction?
Cardiovascular? diseases? including? ischemic? heart? disease? and? stroke? are?major? causes? of?
mortality? worldwide.1? In? recent? genome?wide? association? studies? (GWAS),? the? histone?
deacetylase?9?(HDAC9)?gene?region?(7p21.1)?was?associated?with?large?vessel?stroke?(LVS)2,3?
and?coronary?artery?disease?(CAD).4?In?the?LVS?study,?the?variant?rs2107595,?which?locates?
just? downstream? of? the? HDAC9? gene,? was? identified? as? the? lead? single? nucleotide?
polymorphism?(SNP).3?HDAC9?belongs?to?the?family?of?histone?deacetylases?(HDACs)?which?
consists?of?18?members?grouped?in?4?classes.5?HDAC9?is?a?class?IIa?HDAC?which?in?contrast?
to?class?I?HDACs?are?characterized?by?a?tissue?specific?expression???for?HDAC9?mainly?in?the?
heart,? the?brain?and? the? immune?system? ??as?well?as?by?an?N?terminal?domain?mediating?
interactions?with?transcription?factors?and?transport?proteins.5?7??
Both? LVS? and? CAD? are?mainly? caused? by? atherosclerosis.?We? and? others? could? recently?
demonstrate?that?HDAC9?deficiency?is?atheroprotective?using?two?different?murine?models?
for? atherosclerosis,? ApoE?/?? and? LDLR?/??mice,? respectively.8,9?While? Cao? et? al.? showed? a?
reduction?of?lesion?sizes?in?HDAC9?/?LDLR?/??mice?fed?with?a?Western?type?diet?for?16?weeks,9?
we?made?a?similar?observation? in?aortic?valves?and?the?aortic?arch?of?HDAC9?/?ApoE?/??mice?
at? two? different? time? points? (18? and? 28?weeks? of? age)? and? under? a? normal? chow? diet.8?
Furthermore,?we?observed? that?HDAC9?deficiency? led? to? significantly?more? initial? lesions?
consequently? showing? increased?macrophage? infiltrations.? These? results? are?well? in? line?
with?the?increased?HDAC9?mRNA?levels?we?measured?in?peripheral?blood?mononuclear?cells?
(PBMCs)?of?individuals?carrying?the?rs2107595?risk?allele.8?
Atherosclerosis? is? a? chronic? inflammatory? disease? of? the? arterial? wall.? Both? innate? and?
adaptive? immunity? play? an? important? role? in? the? initiation? and? progression? of?
atherosclerotic? lesions.10? The? predominant? immune? cells? in? atherosclerotic? lesions? are?
macrophages?and?T?cells.?Recent?studies?have?demonstrated?an?involvement?of?HDAC3?and?
HDAC7? in? macrophage? polarization,11?13? as? well? as? on? T? cell? function,? especially? on?
regulatory? T? cells.14,15?Cao? et? al.?observed? in?HDAC9?deficient?macrophages? an? increased?
cholesterol?efflux?via?the?transporter?proteins?ABCA1?and?ABCG1?and?a?polarization?to?the?
more?anti?inflammatory?M2?phenotype.9?A?limitation?of?this?study?was?the?exclusive?ex?vivo?
approach?using?bone?marrow?derived?or?peritoneal?macrophages,?stimulated?and?analyzed?
in?cell?culture?experiments,?while? the? involvement?of?other? immune? cell? types,? such?as?T?
cells,?was?neglected.?The?aim?of? the?current?study?was? to?determine? the?effect?of?HDAC9?
?
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deficiency? on? atherosclerotic? plaque? size? and? immune? cell? homeostasis? after? feeding?
different?diets.?
?
?
Materials?and?Methods?
Animals?
All? animal?protocols?were? approved?by? the? government?of?Upper?Bavaria.?HDAC9?/??mice?
from?E.?Olson7?were?crossed?with?ApoE?deficient?mice?(The?Jackson?Laboratory)?to?generate?
HDAC9?/?ApoE?/??mice.?Mice?had?ad? libitum?access?to?food?and?water?and?were?housed? in?a?
specific?pathogen?free?animal? facility?under?a?12?h? light?dark? cycle.?All?experiments?were?
performed?on?male?littermates?fed?a?standard?chow?diet?for?18?or?28?weeks?or?a?Western?
type?diet? (21.2%? fat,?0.2%? cholesterol,? and?33.2%? sugar,? ssniff)? for?10?weeks,? starting? at?
8?weeks?of? age.?All? experiments? and?data? analysis?were?performed? in? a?blinded? fashion.?
Following?primers?were?used?for?HDAC9?genotyping:?
5’?CAATTGACTATGCGGCTCT?3’?(wt?forward),??
5’?AGGCATGCTGGGGATGCGGTGGGC?3’?(ko?forward),??
5’?CCTTCCATATAAAACCAACTCC?3’?(reverse).?
?
Bone?Marrow?Transplantation?
Bone?marrow?cells?were?isolated?from?femur?and?tibia?of?10?week?old?male?HDAC9+/+ApoE?/??
mice? or? HDAC9?/?ApoE?/?? littermates? and? 1x107? bone? marrow? cells? were? injected?
intravenously? into? lethally? irradiated?6?week?old?male?ApoE?deficient?mice.?For?two?weeks?
after? the? transfer,? animals? were? treated? with? 1? g/L? neomycin? (Sigma?Aldrich).? After?
additional?two?weeks?of?recovery,?mice?were?fed?a?Western?type?diet?for?10?weeks.?
?
Tissue?Harvesting?
Mice? were? anesthetized? using? ketamine? and? xylazine.? Blood? was? obtained? by? cardiac?
puncture.?The?arterial?tree?was?perfused?through?the?left?ventricle?with?phosphate?buffered?
saline?(PBS),?containing?1?mg/ml?sodium?nitroprusside?(Sigma?Aldrich)?for?vasodilation.?The?
spleen?was? removed? prior? to? perfusion?with? 10?ml? of? 1%? paraformaldehyde? (PFA).? The?
aortic?arch?was?dissected?and? fixed? for?24?hours? in?1%?PFA? solution.?Half? the? spleen?was?
used?to?prepare?a?single?cell?suspension?by?mechanical?disruption?using?a?40?μm?nylon?mesh?
?
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(BD? Falcon).? For?RNA? expression? analysis,? the? other? half? of? the? spleen?was? incubated? in?
RNAlater? (QIAGEN)?at?4°C?overnight,? shock?frozen?on?dry? ice? the?next?day?and? stored?at??
?80°C.?
?
Plaque?Size?and?Immunohistochemistry?Analysis?
Atherosclerotic? plaque? size? at? the? aortic? valves? and? in? the? aortic? arch?was? quantified? as?
previously? described.8? In? the?Western?type? diet? fed?mice,? the? acellular? core? area? of? the?
plaque?at?the?brachiocephalic?artery?(BCA)?was?measured?on?two?aortic?arch?sections?at?a?
distance?of?40?μm?by?using?the?Axiovision?software?(Zeiss).??
Immunohistochemistry? was? performed? on? heart? cryosections? at? the? level? of? the? aortic?
valves.? We? used? a? rat? anti?CD45? monoclonal? antibody? (1:200? dilution,? 30?F11,? BD?
Pharmingen)?to?detect?all?infiltrated?leukocytes?and?a?Syrian?hamster?anti?CD3?monoclonal?
antibody?(1:50?dilution,?500A2,?BD?Pharmingen)?to?detect?T?cells.?Antibodies?were?titrated?
to?optimal?performance?and?applied?to?acetone?fixed?cryosections?of?the?aortic?valves.?Goat?
secondary?antibodies?(Vector?Laboratories)?were?used,?followed?by?detection?with?an?ABC?
peroxidase? kit? and? DAB? substrate? (both? from? Vector? Laboratories).? Stainings? were?
quantified?using? ImageJ?Software.?The?CD45+? stained?area?and? the?number?of?CD3+?cells?
inside?the?plaque?or?the?lamina?were?divided?by?the?lesion?area.?
?
Flow?Cytometry?Analysis?
Flow?cytometry?analysis?was?performed?on?single?cell?suspensions?of?spleen?or? leukocytes?
isolated? from? blood.? Cells?were? stained? in? FACS? buffer? (1x? PBS?with? 0.5%?Bovine? Serum?
Albumin? and? 0.01%? sodium? azide)? with? the? following? fluorochrome?labeled? antibodies?
against:?CD45? (eFluor450,?30?F11,?eBioscience),?CD3? (FITC,?145?2C11,?eBisocience),?CD11b?
(PerCp?Cy5.5,?M1/70,?eBioscience),? Ly6G? (PE,?1A8,?BD?Pharmingen),? Ly6C? (APC,?1G7.G10,?
Miltenyi),?CD11c? (PE?Cy7,?N418,?eBioscience),?CD4? (APC?H7,?GK1.5,?BD?Pharmingen),?CD8?
(eFluor450,? 53?6.7,? eBioscience),? CD44? (APC,? IM7,? eBioscience),? CD62L? (PE?Cy7,?Mel?14,?
eBioscience),? and? FoxP3? (PE,? FJK?16a,? eBioscience).? Intracellular? staining? for? FoxP3? was?
performed? using? the? anti?mouse/rat? FoxP3? Staining? Set? (eBioscience).? Samples? were?
acquired? on? the? FACSVerse? (BD? Biosciences)? and? data? analysis? was? done? using? FlowJo?
software?(Tree?Star).?
?
?
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Real?time?PCR?
Total?RNA?from?spleens?of?28?week?old?chow?fed?HDAC9?/?ApoE?/??mice?and?their?wild?type?
littermates?was?isolated?by?RNeasy?Lipid?Tissue?Mini?Kit?(QIAGEN).?cDNA?was?prepared?from?
1?μg?RNA?using?the?Omniscript?RT?Kit?(QIAGEN)?and?diluted?1:5.?For?expression?analysis?of?
interferon??? (IFN??),? a? reaction?mix? of? 12? μl,? including? 2? μl? cDNA,? 200? nM? IFN???specific??
primers? (IFN??? forward:? 5’?TCAAGTGGCATAGATGTGGAAGAA?3’;? IFN??? reverse:??
5’?? TGGCTCTGCAGGATTTTCATG?3’)? and?Brilliant? II? SYBR?Green?QPCR?Master?Mix? (Agilent?
Technologies)?was?used.?For?CXCL1,?CXCL2?and?CXCL5,?PrimeTime?Mini?qPCR?Assays? from?
Integrated?DNA?Technologies?were?used.?Real?time?PCR?was?performed?on?384?well?plates?
using?the?LightCycler?480?(Roche?Diagnostics).?Glyceraldehyde?3?phosphate?dehydrogenase?
(GAPDH)?was?used?as?a?house?keeping?gene.?Measurements?were?performed?in?triplicates.?
Data?were?analyzed?based?on?the?comparative?threshold?cycle?method?with?the?following?
formula:?Relative?mRNA?expression?level?=?2???Ct;??
??Ct?=??Ct,?target????Ct,?calibrator;??Ct?=?Ctarget?gene???Ct,?GAPDH.??
Average?Ct?values?of?wild?type?mice?were?used?as?calibrator.?
?
ELISA?
Splenocytes?were?cultured?in?the?presence?of?anti?CD3?(1?μg/ml,?500A2,?BD?Biosciences)?or?
anti?CD3?plus?anti?CD28?(0.5?μg/ml,?37.51,?eBioscience).?After?48?hours?of?stimulation,?cell?
culture?supernatants?were?collected?and?frozen?at??20°C.?Cytokine?levels?were?measured?by?
matching?antibody?pairs?for?IFN???(BD?Pharmingen),?IL?17?(eBioscience)?and?IL?10?(R&D).?
?
Statistical?analysis?
GraphPad?Prism?6?(GraphPad?Software)?and?SigmaPlot?12.5?(Systat?Software?Inc.)?were?used?
for?statistical?analysis.?Pairwise?comparisons?were?performed?using?the?Mann?Whitney?test.?
Differences?were?considered?statistically?significant?at?P<0.05.?Data?are?expressed?as?mean?
±?SEM.?
?
?
? ?
?
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Results?and?Discussion?
Deficiency?of?HDAC9?has?mainly?an?effect?on?early?atherogenesis??
To? test? the? effect? of? HDAC9? deficiency? on? atherosclerosis? at? various? time? points? using?
different? dietary? settings,? several? groups? of? HDAC9?/?ApoE?/?? mice? and? their? wild?type?
littermates? were? analyzed? (Figure? 1).? Recently,? we? showed? the? influence? of? HDAC9?
deficiency?on?atherosclerotic?plaque?size?in?ApoE?deficient?mice?fed?a?normal?chow?diet.8?At?
both?18? and?28?weeks?of? age,?HDAC9?/?ApoE?/?? animals? showed? a? significant? reduction?of?
atherosclerotic? lesion?size? in?the?aortic?valves?as?well?as? in?the?aortic?arch.? In?addition,?we?
observed? that? HDAC9? deficiency? led? to? significantly? less? advanced? lesions,? and? a?
pronounced?infiltration?of?macrophages.?However,?after?exclusion?of?advanced?atheromas,?
we? no? longer? observed? any? differences? in? the? numbers? of? infiltrating?macrophages? into?
initial? lesions.8? In?the?current?study,?we?analyzed? infiltration?of? leukocytes?(CD45+?cells)?as?
well? as? T? cells? (CD3+? cells)? in? aortic? valve? sections? of? 28?week?old?HDAC9?/?ApoE?/??mice.?
There? were? no? differences,? neither? in? the? overall? leukocyte? infiltration? (Supplementary?
Figure? S1A)? nor? in? the? number? of? T? cells? that?migrated? into? the? lamina? or? the? plaque?
(Supplementary?Figure?S1B).?In?addition?to?18??and?28?week?old?animals?fed?a?normal?chow?
diet,?we?also?added?a?third?group?of?Western?type?diet?fed?mice?and?a?fourth?group?of?bone?
marrow?transplanted?mice?to?our?analysis?(Figure?1).?
?
?
Figure?1.?Study?design.?Four?groups?of?mice?were?analyzed.?The?first?two?groups,?18??and?28?week?
old?HDAC9?/?ApoE?/??mice? and? their?wild?type? littermates?were? fed? a? normal? chow? diet.? The? third?
group? of?mice?was? fed? a? high? cholesterol?Western?type? diet? for? 10?weeks,? starting? at? an? age? of??
8?weeks.?The? fourth? group? consisted?of?ApoE?/??mice?which? received?bone?marrow? from?HDAC9?/?
ApoE?/?? or? from?HDAC9+/+ApoE?/?? donors? after? irradiation.? After? two?weeks? of? antibiotics? and? two?
additional?weeks?of?recovery,?the?mice?were?fed?a?Western?type?diet?for?10?weeks.?
?
?
?
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To? test? the? hypothesis? whether? immune? cells? are? responsible? for? the? atheroprotective?
effect? seen? in?HDAC9?deficient?mice,?we? transplanted?bone?marrow? from?HDAC9?/?ApoE?/??
mice? or?wild?type? littermates? to? lethally? irradiated?ApoE?/??mice? and? after? four?weeks? of?
recovery,?mice?were?fed?a?Western?type?diet?for?10?weeks.?No?differences?in?atherosclerotic?
plaque?size?were?observed? in?Western?type?diet?fed?mice?or? in?bone?marrow?transplanted?
animals,? neither? on? the? level? of? the? aortic? valves? (Figure? 2)? nor? in? the? aortic? arch?
(Supplementary?Figure?S2).?Since?plaque?sizes?were?comparable?between?Western?type?diet?
fed? HDAC9?/?ApoE?/??mice? and? wild?type? littermates,? we? could? not? address? the? question?
whether?HDAC9?deficiency?in?immune?cells?is?sufficient?for?the?atheroprotective?effect.??
For?proteins?important?in?adaptive?immunity?it?is?already?known?that?they?often?only?show?
an? effect? on? atherosclerosis? when? ApoE? deficient?mice? are? fed? a? chow? diet? and? not? a?
Western?type? diet.? For? example,? lymphocyte? deficient? Rag?1? knockout?mice? on? an?ApoE?
deficient?background?showed?a?reduction? in? lesion?size?of?almost?50%?when?fed?a?normal?
chow? diet,? but? no? difference?when? fed? a?Western?type? diet.16? Similar? experiments?were?
performed?by?Song?et?al.? in? LDLR?deficient?mice,?analyzing? the?effect?of?Rag?1?deficiency?
after?different?durations?of?Western?type?diet? feeding.17?After? 8?weeks?on?Western?type?
diet,? Rag1?/?LDLR?/??mice? displayed? a? reduction? of? 54%? in? lesion? size,? while? after? 12? or?
16?weeks,? no? reduction? in? lesion? size? was? observed? any? longer.17? Histological? analysis?
demonstrated?a? lower?complexity?of? lesions? in?Rag1?/?LDLR?/??mice,?which?had?mainly? initial?
foam?cell?lesions,?indicating?an?involvement?of?lymphocytes?in?early?atherogenesis.17?
These? findings? from?Rag?1?deficient?mice?are?comparable? to?our?data?obtained? in?HDAC9?
deficient?animals.?The?biggest?reduction?of?lesion?size?in?HDAC9?deficient?mice?was?seen?at?
18?weeks?of?age?on?chow?diet.?However,? the?difference?was?becoming? smaller?with? time?
(40%?reduction? in?18?week?old?vs.?26.5%?reduction? in?28?week?old?HDAC9?/?ApoE?/??mice? in?
comparison? to? HDAC9+/+ApoE?/?? mice),? indicating? a? delay? of? atherogenesis? by? HDAC9?
deficiency.? This? is? supported?by?histological?data? from?our?previous? study? showing?more?
initial?lesions?in?HDAC9?/?ApoE?/??mice.8?
?
?
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Figure?2.?HDAC9?deficiency?has?no?effect?on?atherosclerotic?plaque?size? in?Western?type?diet? fed?
mice.?A,?Representative? images?showing?Oil?Red?O??and?hematoxylin?stained?cryosections?from?the?
proximal?aorta?of?HDAC9+/+ApoE?/??and?HDAC9?/?ApoE?/??mice? fed?a?Western?type?diet? (WD)?or?after?
bone?marrow?transplantation?(BMT).?Scale?bars:?250?μm.?B,?Quantification?of?the?relative?lesion?area?
(in? relation? to? the?area? inside? the?external?elastic? lamina)?demonstrates?a? significant? reduction?of?
atherosclerosis? in?18?? and?28?week?old?HDAC9?/?ApoE?/??mice?on? chow?diet? in? comparison? to? their?
wild?type?littermates,8?but?no?differences?in?Western?type?diet?and?bone?marrow?transplanted?mice.?
Results? represent?mean?±?SEM;?n?=?7?13? for?each?genotype?and? time?point;?*P<0.05?vs.?wild?type?
(Mann?Whitney?test).?
?
To? further? validate? this? finding,? we? analyzed? the? amount? of? acellular? cores? in? the?
brachiocephalic? artery? of? Western?type? diet? mice.? In? contrast? to? 28?week?old? HDAC9?
deficient?mice?on?chow?diet,?which? showed?a? significant? reduction?of?acellular?cores,8?no?
difference? in? the?acellular?cores?was?observed? in?HDAC9?/?ApoE?/??mice?compared? to?wild?
type?littermates?fed?a?Western?type?diet?(Figure?3).?These?findings?indicate?an?involvement?
of?HDAC9? in?early?atherogenesis.?To?answer? the?question? if?HDAC9?deficiency? in? immune?
cells? is?sufficient?for?an?atheroprotective?effect,? it? is?necessary?to?perform?a?bone?marrow?
?
?
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transplantation?in?ApoE?deficient?mice?fed?a?normal?chow?diet?or?a?Western?type?diet?for?a?
shorter?duration.?
?
?
Figure?3.?Western?type?diet?fed?HDAC9?/?ApoE?/??mice?have?similar?proportions?of?acellular?cores?in?
atherosclerotic?lesions?as?wild?type?littermates.?A,?Representative?images?of?atherosclerotic?plaques?
in?the?brachiocephalic?artery?(BCA)?of?HDAC9?/?ApoE?/??and?HDAC9+/+ApoE?/??mice.?Scale?bars:?100?μm.?
B,?Quantification?of?acellular?core?per?lesion?area?in?the?BCA?of?Western?type?diet?fed?HDAC9?/?ApoE?/??
mice?and?their?wild?type?littermates.?n?=?10?11?for?each?genotype.?
?
HDAC9?deficiency?affects?monocyte?populations?in?atherosclerotic?mice?
To? study? the? distribution? of? different? leukocyte? subpopulations? in?HDAC9? deficient?mice?
during?atherosclerosis,?flow?cytometry?analysis?of?the?spleen?and?the?blood?was?performed?
with? specific? immune? cell?markers.?Blood? leukocyte?analysis?did?not? reveal?differences? in?
the? leukocyte?populations? investigated?(data?not?shown).?HDAC9?/?ApoE?/??mice?on?chow?as?
well? as? on? Western?type? diet? had? a? lower? percentage? of? monocytes/macrophages?
(CD11b+Ly6G?)? in? the? spleen? (Figure? 4A? and? 4B).? Moreover,? when? we? compared? the?
classical,?pro?inflammatory?Ly6C+?monocytes?with?non?classical,?resident?Ly6C??monocytes,?
a? shift? toward? the? latter?population?was?observed? in?HDAC9?deficient?mice? (Figure?4?and?
Supplementary?Figure?S3),?a?finding? in? line?with?the?observed?reduction? in? lesion?size.?This?
shift? in?Ly6C?was?only?observed? in?HDAC9?/?ApoE?/??mice?but?not? in?HDAC9?single?knockout?
mice? (Supplementary? Figure? S3D),? indicating? that? it? represents? a? disease?specific? effect.?
Differences?were?also?detected? in?neutrophil?percentages?(CD11b+Ly6G+).?However,?these?
were? not? consistent? between? 18?? and? 28?week?old?mice? (Figure? 4A? and? Supplementary?
Figure?S3A).?HDAC9?deficient?mice? showed?no?differences? in?CD11c+?dendritic?cells? (data?
not? shown).? Additionally,? we? also? checked? the? expression? of? different? cytokines? and?
chemokines? which? are? important? for?macrophage? and? neutrophil? function/migration? in?
?
?
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spleens? from? 28?week?old? mice.? Expression? of? IFN??,? CXCL1,? CXCL2? and? CXCL5? was?
comparable?between?HDAC9+/+ApoE?/??and?HDAC9?/?ApoE?/??mice?(Supplementary?Figure?S4).?
?
?
Figure? 4.? HDAC9?/?ApoE?/?? mice? show? reduced? monocyte? numbers? and? a? shift? to? more? Ly6C?
negative,?non?classical,?resident?monocytes.?Flow?cytometric?analysis?of?spleens?from?18?week?old?
and?Western?type?diet?(WD)?fed?HDAC9+/+ApoE?/??and?HDAC9?/?ApoE?/??mice.?A?and?B,?Frequencies?of?
monocytes/macrophages?(CD11b+Ly6G?)?and?neutrophils?(CD11b+Ly6G+)?(%?of?leukocytes).?C?and?D,?
Frequencies?of?Ly6C+?and?Ly6C??monocytes/macrophages?(%?of?CD11b+Ly6G??cells).?n?=?9?13?mice?for?
each?genotype?per?group.?*P<0.05;?**P<0.01.?
?
HDAC9?/?ApoE?/??mice?have?a?modest?decrease?in?regulatory?T?cells??
To?investigate?possible?effects?of?HDAC9?deficiency?on?cells?of?the?adaptive?immune?system,?
we? analyzed? T? cell? populations? by? flow? cytometry.?We? detected? no? differences? in? the?
frequencies?of?T?cells?(CD3+),?the?T?helper?cell?subpopulation?(CD4+)?or?the?cytotoxic?T?cell?
subpopulation?(CD8+)?(Figure?5A,?5B,?Supplementary?Figure?S5A?and?S5B).?Surprisingly,?we?
measured?a?modest?decrease?in?regulatory?T?cells?(CD4+FoxP3+)?in?our?HDAC9?/?ApoE?/??mice?
on?chow?and?on?Western?type?diet?(Figure?5C,?5D?and?Supplementary?Figure?S5C),?but?not?
in?HDAC9?deficient?mice?without?ApoE?deficiency?(Supplementary?Figure?S5D).?
?
?
?
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Figure? 5.? HDAC9?/?ApoE?/??mice? show? a?modest? decrease? in? regulatory? T? cells.? Flow? cytometric?
analysis?of?spleens?from?18?week?old?and?Western?type?diet?(WD)?fed?HDAC9+/+ApoE?/??and?HDAC9?/?
ApoE?/??mice.?A?and?B,?Frequencies?of?T?cells?(CD3+),?T?helper?cells?(CD3+CD4+)?and?cytotoxic?T?cells?
(CD3+CD8+)?(%?of?leukocytes).?C?and?D,?Frequencies?of?CD4+FoxP3+?regulatory?T?cells.?n?=?9?13?mice?
for?each?genotype?per?group.?*P<0.05.?
?
These? findings? are? in? contrast? to? previously? published? data? by? Tao? et? al.? showing? that?
HDAC9? deficient?mice? have? a? 50%? increase? in? CD4+FoxP3+? T? cells.15? Different?wild?type?
controls? may? account? for? these? contradictory? observations.? In? our? study,? wild?type?
littermates?were?used.?It?is,?however,?not?clear?which?controls?the?Tao?et?al.?study?used?for?
the? analysis.? Furthermore,? only? a? number? of? 4? spleens? were? measured? by? Tao? and?
colleagues,15?while?a?minimum?of?8?HDAC9?/?ApoE?/??mice?were?used? in? the? three?different?
groups?in?our?study.?Nevertheless,?our?data?do?not?allow?the?conclusion?that?HDAC9?has?no?
influence?on?regulatory?T?cells,?since?the?study?by?Tao?et?al.?convincingly?demonstrated?that?
HDACs,?especially?HDAC9,?are? important?for?the?suppressive?function?of?regulatory?T?cells.?
Our?modest?decrease?in?regulatory?T?cells?has?probably?no?consequence?on?atherosclerosis.?
Nevertheless,?these?cells?could?still?be?more?suppressive?than?wild?type?regulatory?T?cells.??
In? addition? to? flow? cytometry? analysis,?we? assessed? the? ability? of? T? cells? to? respond? to?
antigen? stimulation? using? the? production? of? pro?inflammatory? (IFN??? or? IL?17)? or? anti?
inflammatory? (IL?10)?cytokines?as?a? read?out?system.?Splenocytes? from?chow?or?Western?
type? diet? fed? HDAC9?/?ApoE?/??mice? showed? similar? patterns? of? cytokine? secretion?when?
?
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stimulated?in?vitro?with?anti?CD3?or?anti?CD3/CD28?antibodies?(Figure?6).?This?data?suggests?
that? despite? the? lack? of? HDAC9,? antigen?presenting? cells? can? efficiently? prime??
T? lymphocytes,? that?HDAC9? deficient? T? cells? recognize? and? respond? normally? to? antigen?
encounter?and?that?the?effector?T?cell?response? is?not?disturbed? in?HDAC9?deficient?mice.?
Hence,?other?immune?cells/pathways/mechanisms?are?responsible?for?the?atheroprotective?
effect?seen?in?HDAC9?deficient?mice.?
?
?
Figure? 6.?HDAC9? deficiency? has? no? influence? on? cytokine? expression? of? splenocytes? after? T? cell?
stimulation.? Splenocytes? from? 18?week?old? and?Western?type? diet? (WD)? fed?HDAC9+/+ApoE?/?? and??
HDAC9?/?ApoE?/??mice?were?stimulated?for?48?hours?with?anti?CD3?or?anti?CD3/anti?CD28?antibodies.?
Levels?of?IFN???(A?and?D),?IL?17?(B?and?E)?and?IL?10?(C?and?F)?were?measured?in?the?supernatants?by?
ELISA.?All?graphs?represent?mean?±?SEM;?n?=?6?7?mice?for?each?genotype?per?group.?
?
?
?
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HDAC9?/?ApoE?/??mice?show?a?reduction?in?CD4+?effector?memory?T?cells?
Besides? regulatory? T? cells,?we? also? checked? the?memory? T? cell? populations? by? using? the?
CD44? and? the? CD62L? (L?selectin,? homing? receptor)? markers.? Interestingly,? chow? fed??
HDAC9?/?ApoE?/?? mice? showed? a? decrease? in? effector? memory? T? cells? within? the? CD4+?
population?(Figure?7?and?Supplementary?Figure?S6A).?This?difference?was?only?observed? in?
normal?chow?but?not?in?Western?type?diet?fed?mice?(Figure?7B)?or?in?HDAC9?deficient?mice?
without? ApoE? deficiency? (Supplementary? Figure? S6B).? The? decrease? in? effector?memory??
T?cells?could?explain?the?reduced?atherosclerosis? in?chow?fed?HDAC9?/?ApoE?/??mice,?due?to?
less?activation?and?mobilization?of?T? cells.?Ammirati?et?al.?demonstrated?a? correlation?of?
CD4+? effector?memory? T? cells?with? the? extent? of? atherosclerosis? in? animals? and? carotid?
intima?media?thickness?in?humans.18?These?data?are?well?in?line?with?our?findings.??
?
?
Figure? 7.? HDAC9?/?ApoE?/?? mice? have? less? effector?memory? T? cells.? Flow? cytometric? analysis? of?
spleens? from? 18?week?old? and?Western?type? diet? (WD)? fed? HDAC9+/+ApoE?/?? and? HDAC9?/?ApoE?/??
mice.? A? and? B,? Frequencies? of? naïve? (CD44lowCD62Lhigh),? central?memory? (CD44highCD62Lhigh)? and?
effector?memory? (CD44highCD62Llow)?T?cells?within? the?CD4+?T?cell?population?are? shown.?n?=?9?13?
mice?for?each?genotype?per?group.?**P<0.01.?
?
?
?
?
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In?conclusion,?the?present?study?highlights?the?importance?of?HDAC9?in?early?atherogenesis.?
We? could? show? that? HDAC9? deficiency? leads? to? a? delay? of? atheroprogression.? HDAC9?
deficient?mice?on?chow?diet?had? less?advanced? lesions,?but?similar? immune?cell? infiltration?
into? the?plaques.?We?demonstrate? a? shift? in?monocyte/macrophage?populations?by? flow?
cytometry?which?is?in?line?with?the?M2?anti?inflammatory?phenotype?which?Cao?et?al.?could?
recently?show?in?peritoneal?macrophages?from?HDAC9?/?LDLR?/??mice.9?Besides?macrophages,?
also?T? cells? seem? to?play? an? important? role? in?HDAC9?deficient?mice.?Chow? fed?HDAC9?/?
ApoE?/??mice?show?less?effector?memory?T?cells?which?fits?to?the?reduced?atherosclerosis?in?
these? mice.? Additional? functional? experiments? are? necessary? to? delineate? the? exact?
mechanism? and? interaction? of? different? cell? types? leading? to? the? atheroprotective? effect?
mediated? by? HDAC9? deficiency.? HDAC9? inhibition? seems? to? be? a? promising? therapeutic?
strategy?for?the?prevention?of?atherosclerosis.?
?
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Supplementary?Figures?
?
?
?
Supplementary? Figure? S1.? HDAC9? deficiency? has? no? effect? on? immune? cell? infiltration? in?
atherosclerotic?plaques.?A,?Quantification?of?CD45?positive?stained?area?in?atherosclerotic?plaques?of?
the?aortic?valves?showed?no?difference?in?leukocyte?infiltration?between?28?week?old?HDAC9?/?ApoE?/??
mice?and?their?wild?type?littermates.?B,?Quantification?of?CD3+?cells?in?the?lamina?(red?arrow)?and?in?
the?plaque?(blue?arrow)?of?aortic?valve?sections?showed?no?difference?in?T?cell?infiltration?of?28?week?
old?mice.?Scale?bars:?100?μm;?n?=?8?13?for?each?genotype.?
?
?
?
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Supplementary? Figure? S2.? HDAC9? deficiency? has? no? effect? on? atherosclerotic? plaque? size? in?
Western?type?diet?fed?or?bone?marrow?transplanted?mice?on?Western?type?diet.?A,?Representative?
images? showing? dissected? aortic? arches? and? quantification? of? lesion? sizes? at? the?main? branching?
arteries?and?aortic?curvature?of?Western?type?diet?(WD)?fed?(A)?and?bone?marrow?transplanted?mice?
(BMT)?(B).?BCA?brachiocephalic?artery,?CCA?common?carotid?artery,?SCA?subclavian?artery.?All?graphs?
represent?mean?±?SEM;?n?=?7?11?mice?for?each?genotype?per?group.?
?
?
?
?
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Supplementary?Figure?S3.?HDAC9?/?ApoE?/??mice? show? reduced?monocyte?numbers?and?a? shift? to?
more? Ly6C?negative,?non?classical,? resident?monocytes.?Flow? cytometric?analysis?of? spleens? from?
28?week?old? HDAC9+/+ApoE?/?? and? HDAC9?/?ApoE?/?? mice? and? 20?week?old? HDAC9+/+? and? HDAC9?/??
mice.? A? and? B,? Frequencies? of? monocytes/macrophages? (CD11b+Ly6G?)? and? neutrophils?
(CD11b+Ly6G+)?(%?of?leukocytes).?C?and?D,?Frequencies?of?Ly6C+?and?Ly6C??monocytes/macrophages?
(%?of?CD11b+Ly6G??cells).?n?=?5?13?mice?for?each?genotype?per?group.?*P<0.05;?***P<0.001.?
?
?
?
Supplementary? Figure? S4.? HDAC9? deficiency? does? not? influence? cytokine? and? chemokine?
expression?in?the?spleen.?mRNA?expression?levels?of?IFN??,?CXCL1,?CXCL2?and?CXCL5?were?measured?
in? the? spleen? of? 28?week?old? HDAC9?/?ApoE?/?? and? HDAC9+/+ApoE?/??mice.? n? =? 8?13?mice? for? each?
genotype.?All?graphs?represent?mean?±?SEM.?
?
?
?
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Supplementary?Figure?S5.?HDAC9?/?ApoE?/??mice?show?a?modest?decrease?in?regulatory?T?cells.?Flow?
cytometric? analysis? of? spleens? from? 28?week?old? HDAC9+/+ApoE?/?? and? HDAC9?/?ApoE?/?? mice? and??
20?week?old? HDAC9+/+? and? HDAC9?/??mice.?A? and? B,? Frequencies? of? T? cells? (CD3+),? T? helper? cells?
(CD3+CD4+)?and?cytotoxic?T?cells?(CD3+CD8+)?(%?of?leukocytes).?C?and?D,?Frequencies?of?CD4+FoxP3+?
regulatory?T?cells.?n?=?5?13?mice?for?each?genotype?per?group.?*P<0.05.?
?
?
?
?
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Supplementary?Figure?S6.?HDAC9?/?ApoE?/??mice?have?less?effector?memory?T?cells.?Flow?cytometric?
analysis? of? spleens? from? 28?week?old?HDAC9+/+ApoE?/?? and?HDAC9?/?ApoE?/??mice? and? 20?week?old?
HDAC9+/+? and? HDAC9?/??mice.? A? and? B,? Frequencies? of? naïve? (CD44lowCD62Lhigh),? central?memory?
(CD44highCD62Lhigh)?and?effector?memory?(CD44highCD62Llow)?T?cells?within?the?CD4+?T?cell?population.?
n?=?5?13?mice?for?each?genotype?per?group.?*P<0.05;?**P<0.01.?
?
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Abstract?
The?histone?deacetylase?9?(HDAC9)?gene?region?at?chromosome?7p21.1?has?been?identified?
as?a?major? risk? locus? for?atherosclerotic? stroke?and?HDAC9?deficiency?attenuated?disease?
progression? in?experimental?models?of?atherosclerosis? in?mice.?Since? this?makes?HDAC9?a?
potential?drug? target? for? stroke?prevention,?we?wanted? to?evaluate? the? role?of?HDAC9? in?
acute?ischemic?stroke.??
HDAC9?mRNA?levels?significantly?increased,?almost?two?fold,?in?the?ischemic?brain?2?3?hours?
after?60?min?of?middle?cerebral?artery?occlusion?followed?by?reperfusion.?
HDAC9?deficient?mice?showed?significantly? larger? infarct?volumes?and? increased?cell?death?
in? peri?ischemic? areas? 24? hours? after? stroke.? The? difference? in? infarct? volume? (+40%)?
persisted? until? one? week? after? ischemia? and? was? accompanied? by? worse? neurological?
scores.? Blood? pressure,? arterial? blood? gases,? plasma? electrolytes,? vascular? anatomy,?
reperfusion,?and?brain?edema?formation?were?not?different?between?HDAC9?deficient?mice?
and?their?wild?type?littermates.?
Our? results? suggest? a? protective? role? of? HDAC9? in? acute? ischemic? stroke.? Therapeutic?
strategies? to? reduce? atherogenesis? and,? hence,? stroke? incidence? by? inhibition? of?HDAC9?
should?therefore?account?for?potential?effects?in?acute?ischemic?stroke.?
?
? ?
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Introduction?
Genome?wide?association?studies?have? identified?the?histone?deacetylase?9? (HDAC9)?gene?
region?(7p21.1)?as?the?so?far?strongest?risk?locus?for?large?vessel?stroke.1,2?Common?variants?
at? this? locus? were? further? found? to? be? associated? with? coronary? artery? disease3? and?
common? carotid? intima?media? thickness.4? We? recently? showed? that? the? risk? allele? of?
rs2107595,?the? lead?single?nucleotide?polymorphism? (SNP)? in?METASTROKE,2? is?associated?
with? elevated?HDAC9?mRNA? expression? in? peripheral? blood?mononuclear? cells.5?We? and?
others? further?demonstrated? that?HDAC9?deficiency? is?atheroprotective? in?mouse?models?
for?atherosclerosis,?making? targeted? inhibition?of?HDAC9?a?potentially?promising? strategy?
for?prevention?of?atheroprogression?and,?hence,?large?vessel?stroke.5,6?
HDAC9?belongs?to?the?family?of?histone?deacetylases?(HDACs)?which?removes?acetyl?groups?
from? lysine? residues? of? histones? and? other? non?histone? proteins,? thus? regulating? gene?
expression.?The?group?of?HDACs?consists?of?18?enzymes?which?can?be?classified?according?to?
their?molecular?structure,?cofactors,?and?subcellular?localization.?HDAC9?is?a?class?IIa?HDAC?
and?like?all?classical?HDACs?requires?Zn2+?for?its?activity.7,8?Acetylation?homeostasis?plays?an?
important?role?in?neuronal?survival?and?in?neurodegenerative?disorders.9,10?HDAC?inhibitors?
have? been? shown? to? exhibit? neuroprotective? properties? in? several? experimental? stroke?
models.11?13? Available? pan? HDAC? inhibitors? exhibit? side?effects? and? in? vitro? studies? have?
demonstrated?potential?neuroprotective?effects?of?specific?HDAC?family?members,?including?
HDAC9.14,15?Hence,?there? is?growing? interest? in?delineating?the? impact?of? individual?HDACs?
on?neuronal?survival.?To?characterize?the?role?of?HDAC9?in?acute?ischemic?stroke?in?vivo,?we?
investigated?the?expression?of?HDAC9?in?ischemic?brain?and?subjected?HDAC9?deficient?mice?
to?transient?middle?cerebral?artery?occlusion?(MCAo).?
?
?
Materials?and?Methods?
All?animal?studies?were?approved?by?the?Ethical?Review?Board?of?the?Government?of?Upper?
Bavaria?(protocol?number?55.2?1?54?2532?187?13)?and?were?performed?in?accordance?with?
national? and? institutional? guidelines.?Male? C57BL/6? (18? to? 22? g,? Charles? River,? Sulzfeld,?
Germany)? and?male,? 6?week?old? HDAC9? deficient? (HDAC9?/?)?mice,? initially? generated? by?
E.?Olson16,? and? their?wild?type? littermates?were? used.? All? surgeries,? quantifications,? and?
?
?
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analyses?were?done? in? a? randomized?manner? and? assessed?by?blinded? investigators.?The?
results?are?reported?according?to?the?ARRIVE?guidelines.?
?
Transient?Middle?Cerebral?Artery?Occlusion?Model?
Transient? middle? cerebral? artery? occlusion? (MCAo)? was? performed? as? previously?
described.17,18?30?minutes?prior?to?surgery,?analgesia?was?provided?with?carprofen?(4?mg/kg?
s.c.).?Anesthesia?was?induced?using?4%?isoflurane?in?a?gas?mixture?of?30%?oxygen?and?70%?
nitrous? oxide? and? maintained? with? 1.5%? isoflurane? during? surgery? (15?20? minutes).? A?
feedback?controlled?heating?pad?was?used?to?maintain?body?temperature?at?37°C.?Regional?
cerebral?blood?flow?(CBF)?in?the?MCA?territory?was?monitored?continuously?using?a?flexible?
laser? Doppler? probe? (PeriFlux? System? 5000,? Perimed,? Järfälla,? Sweden)? glued? onto? the?
exposed?left?temporal?bone.?After?ligation?of?the?left?common?and?external?carotid?arteries,?
a? silicone?coated? 7?0?monofilament? (7019PK5Re,? Doccol? Corporation,? Sharon,?MA)? was?
introduced?into?the?internal?carotid?artery?and?advanced?further?to?occlude?the?MCA?origin,?
resulting?in?a?CBF?drop?below?25%?of?baseline.?After?occlusion,?the?wounds?were?closed?and?
the?animals?were?allowed? to?wake?up.?After?1?hour?of?MCA?occlusion,?mice?were? shortly??
reanesthetized? and? the? filament? was? withdrawn.? In? sham?operated? animals,? the?
monofilament?was?placed?into?the?internal?carotid?artery?without?occlusion?of?the?MCA.?
?
Tissue?Harvesting?for?Expression?Analyses?
Brains? from?C57BL/6?mice? sacrificed?1h,?3h,?6h,?or?24h? after?MCA?occlusion?were? cut? in?
2?mm? thick? coronal? slices? (from? Bregma? to? Bregma? ?2?mm)? using? a? brain?matrix? (Zivic?
Instruments,?Pittsburgh,?PA).?The?peri?infarct?region,?infarct?core,?contralateral?cortex,?and?
contralateral?striatum?were?dissected? (Figure?1A),? incubated? in?RNAlater?(QIAGEN,?Hilden,?
Germany)?at?4°C?overnight?and?then?shock?frozen?on?dry?ice.?
?
Real?time?PCR?
Total? RNA?was? isolated? by? RNeasy? Lipid? Tissue?Mini? Kit? (QIAGEN,?Hilden,?Germany)? and?
cDNA?was?prepared? from?1?μg?RNA?by? the?Omniscript?RT?Kit? (QIAGEN,?Hilden,?Germany).?
cDNA?was?diluted? 1:20? and? added? to? 200?nM? gene? specific?primers? and?Brilliant? II? SYBR?
Green?QPCR?Master?Mix? (Agilent?Technologies,? Santa?Clara,?CA).?A? total? volume?of?12?μl?
(including?2?μl?cDNA)?was?used.?Real?time?PCR?was?performed?on?384?well?plates?using?the?
?
?
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LightCycler? 480? (Roche? Diagnostics,? Basel,? Switzerland).? Hypoxanthine?guanine?
phosphoribosyl?transferase?(HPRT)?was?used?as?a?house?keeping?gene.?Data?were?analyzed?
based? on? the? comparative? threshold? cycle?method?with? the? following? formula:? Relative?
mRNA?expression?level?=?2???Ct;???Ct?=??Ct,?target????Ct,?calibrator;??Ct?=?Ct,?HDAC9???Ct,?HPRT.?
The?corresponding?sample?from?the?contralateral?hemisphere?was?used?as?calibrator.?
Following?primers?were?designed? for?Real?time?PCR:?5’?CAATACCAGCAGCAGATCCA?3’?and?
5’?GATTGGTCCCCCTGAAGC?3’? (for? HDAC9);? 5’?GATTAGCGATGATGAACCAGGTT?3’? and??
5’?CCTCCCATCTCCTTCATGACA?3’?(for?HPRT).?
?
Infarct?Volume?Analysis?
Infarct? analysis?was? performed? as? previously? described.18? Briefly,?mice?were? euthanized?
24?hours?or?7?days? after?MCAo?by? cervical?dislocation? in?deep? isoflurane? anesthesia? and?
brains?were? removed?and? shock?frozen?on?dry? ice.?12?coronal?cryosections? (10?μm)?were?
cut?at?an? interval?of?750?μm?and? then? stained?with? cresyl?violet.? Infarct?and?hemisphere?
areas?were?measured?using?a?calibrated?microscope?and?AxioVision?Software? (Zeiss,? Jena,?
Germany)?and?the? infarct?volume?was?calculated?and?corrected?for?brain?edema?using?the?
following?formula:?
?Ainfarct,?corr?=?Acontralateral?hemisphere???(Aipsilateral?hemisphere???Ainfarct);?
?Vinfarct?=?(Asection1+…+Asection12)?*?750?μm.?
Infarct? volumes? are? expressed? as? percentages? of? the? volume? of? the? contralateral?
hemisphere.?
?
Assessment?of?the?Vascular?Anatomy?in?HDAC9?/??mice?
Mice?were? transcardially?perfused?with? saline?and?0.5?ml? India? ink? in?deep?ketamine?and?
xylazine?anesthesia.?Brains?were?removed?and?the?MCA?territory?of?both?hemispheres?and?
both?posterior?communicating?arteries?(PComA)?were?imaged.?The?diameter?of?the?PComA?
was? scored? as? previously? described? (Score? 0?3;? 0? =? absence? of? PComA,? Score? 3? =? fully?
developed?PComA).18,19?The?territory?of?the?dorsal?brain?surface?perfused?by?the?MCA?was?
expressed?as?percentage?of?the?hemisphere?surface.?
?
?
?
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Functional?Outcome?
A?modified,?five?point?Bederson?test?was?performed?as?previously?described.20?Briefly,?the?
scores?were? the? following:? 0? =? normal? neurological? behavior;? 1? =? no? circling,? but? clear?
asymmetry?in?forepaw?movement,?when?lifted?by?the?tail;?2?=?clear?circling?to?contralateral?
side,?but?normal?posture?at?rest;?3?=?lying?on?contralateral?side?at?rest;?4?=?no?spontaneous?
movement.?Scores?of?0.5,?1.5?and?2.5?were?assigned?when?an?intermediate?phenotype?was?
observed.?The?tests?were?done?in?the?evening?throughout?the?observation?period?of?7?days?
in?parallel?with?measurements?of?body?weight.?
?
Physiological?Monitoring?before?and?after?MCAo?
Anesthesia?was?induced?with?4%?isoflurane?and?continued?by?an?intraperitoneal?injection?of?
fentanyl? (0.05?mg/kg),?midazolam? (5?mg/kg),? and?medetomidine? (0.5?mg/kg).? After? one?
hour,?anesthesia?was?maintained?by? injecting?one?third?of?the? initial?dose.?Mice?were?oro?
tracheally?intubated?and?mechanically?ventilated?with?a?mixture?of?70%?air?and?30%?oxygen.?
A?catheter?was?placed?in?the?left?carotid?artery?for?measuring?mean?arterial?blood?pressure?
(MAP)?continuously?and?electrolytes?and?blood?gases?at?the?beginning?and?the?end?of?each?
experiment.?MCA?occlusion?was?performed?as?described?above.?
?
Brain?Edema?
Brains? from?HDAC9?/??mice? and? their?wild?type? littermates?were? removed? 24? hours? after?
MCAo.?After?separation?of?the?hemispheres,?the?wet?weight? (W)?of?each?hemisphere?was?
measured.?Thereafter,? the?hemispheres?were? incubated?at?110°C? in?an?oven? for?24?hours?
and?weighed?again?to?determine?the?dry?weight?(D).?Water?content?of?each?hemisphere?was?
determined?with?the?following?formula:?((W?D)/W)?*?100%.?
?
TUNEL?Staining?
Cryosections?were? stained? for?cell?death?using? the?ApopTag?Fluorescein? In?Situ?Apoptosis?
Detection? Kit? (Merck? Millipore,? Darmstadt,? Germany).? Two? brain? sections? at? Bregma??
?1.5?mm?and??3?mm?were?selected?per?animal.?Two?regions?of?interest?(ROI)?were?analyzed?
on?each? section,?one?at? the?border?of? the?MCA?and?ACA? territory? (ROI1)?and?one?at? the?
piriform?cortex? (ROI2),?a? region?specifically?prone? to?selective?post?ischemic?neuronal?cell?
death.?A?counting?window?of?0.075?mm2?was?placed?at? the?border?of? the?TUNEL?positive?
?
?
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area?and?only?the?strong?TUNEL?positive?cells?were?counted?by?using?global?threshold.?The?
quantification?was? done? twice? by? two? independent,? blinded? investigators.? The? averaged?
means?of?both?brain?sections?are?shown.?
?
Statistical?Analysis?
Statistical?analysis?was?performed?using?SigmaPlot?12.5?(Systat?Software?Inc.,?San?Jose,?CA).?
Pairwise?comparisons?were?performed?using?the?Mann?Whitney?rank?sum?test.?Differences?
were?considered?statistically?significant?at?P<0.05.?Data?are?presented?as?Box?Whisker?Plots?
indicating?the?median?and?the?90th,?75th,?25th,?and?10th?percentiles?or?as?mean?±?SEM.?
?
?
Results?
HDAC9?expression?increases?after?MCAo?
HDAC9?mRNA? expression?was? analyzed? at? different? time? points? after?MCAo? in? the? peri?
infarct?region?and?the? infarct?core?of?C57BL/6?mice.?The?peri?infarct?region?and?the? infarct?
core? were? dissected? as? shown? in? Figure? 1A.? Besides? 24h? sham,? two? additional? control?
groups? were? used,? 3h? sham? and? naïve? brains? (without? surgery).? All? control? groups?
demonstrated? the? same? HDAC9? baseline? expression? (data? not? shown).? HDAC9? mRNA?
expression?was?significantly?upregulated?1?hour?and?3?hours?after?MCAo?both? in?the?peri?
infarct?region? (Figure?1B)?and? in?the? infarct?core? (Figure?1C)? (1.4?1.9? fold? increase;?P<0.05?
versus? 24h? sham).? HDAC9? expression? decreased? subsequently? and? reached? 62%? in? the?
infarct?core?at?24?hours?after?MCAo?(P<0.05?versus?24h?sham;?Figure?1C).??
?
?
?
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Figure? 1.? HDAC9?mRNA? expression? after?MCAo? in? C57BL/6?mice.? (A)? Schematic? drawing? of? how?
coronal?brain?sections?were?dissected?for?RNA?analysis.?CLC:?contralateral?cortex,?CLS:?contralateral?
striatum,?IC:?infarct?core,?PIR:?peri?infarct?region.?(B?and?C)?HDAC9?mRNA?expression?increased?in?the?
PIR? and? the? IC? within? 1?3? hours? after? MCAo? and? decreased? thereafter? in? comparison? to? the?
corresponding? contralateral?brain? regions.?HDAC9?expression?was?normalized? to?HPRT?expression.?
Results?represent?mean?±?SEM.?*P<0.05.?
?
HDAC9?deficiency?increases?infarct?size?24?hours?and?7?days?after?MCAo?
To?explore?the?effect?of?HDAC9?deficiency? in?acute? ischemic?stroke,?HDAC9?deficient?mice?
were? subjected? to?1?hour?of?MCA?occlusion?and?23?hours?of? reperfusion.?24?hours?after?
MCAo,?HDAC9?deficient?mice?showed?significantly?increased?infarct?areas?at?the?level?of?the?
coronal?sections?covering? the?MCA? territory? (Figure?2A),?and? their?overall? infarct?volumes?
were? significantly? larger?as?compared? to?wild?type?mice? (28%?±?7%?and?32%?±?3%?of? the?
?
?
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contralateral?hemisphere?for?HDAC9+/+?and?HDAC9?/??mice,?respectively;?mean?±?SD;?P<0.05;?
Figure? 2B).? In? an? additional? group? with? a? 7? days? observation? period,? increased? infarct?
volumes? were? still? present? in? HDAC9? deficient?mice? (25%? ±? 8%? and? 35%? ±? 7%? of? the?
contralateral?hemisphere?for?HDAC9+/+?and?HDAC9?/??mice,?respectively;?mean?±?SD;?P<0.05;?
Figure?2C?and?2D);?the?difference?between?both?groups?was?even?more?pronounced?(+40%?
as?compared?to?+14%?at?day?1;?P<0.05;?Figure?2D).?
?
?
Figure?2.?Infarct?volume?analysis?24?hours?and?7?days?after?MCAo.?(A)?Representative?sections?from?
HDAC9+/+?and?HDAC9?/??mice?and?infarct?area?analysis?showed?larger?areas?of?infarcted?brain?tissue?at?
the? level?of? the?MCA? territory?on?coronal? sections?24?hours?after?MCAo? in?HDAC9?deficient?mice.??
(B)?Volumetric?calculation?of?infarct?sizes?revealed?significantly?increased?infarcts?in?HDAC9?deficient?
mice?24?hours?after?MCAo.?(C?and?D)?The?difference?in?infarct?volume?between?HDAC9?deficient?mice?
and? their?wild?type? littermates?was? still? present? and? even?more? pronounced? 7? days? after?MCAo?
(+40%).?*P<0.05,?**P<0.01.?
?
To?exclude?that?differences?in?vascular?anatomy?influence?peri?infarct?perfusion?and,?hence,?
infarct?volume,?we?evaluated?the?vasculature? in?HDAC9?/??and?HDAC9+/+?mice?by?perfusion?
with? India? ink.? The?MCA? territory? as?well? as? the?degree?of? collateralization?between? the?
?
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anterior?and?the?posterior?vascular?territories?did?not?differ?between?HDAC9?deficient?mice?
and?their?wild?type?littermates?(Figure?3).??
?
?
Figure? 3.? Characterization? of? vascular? anatomy? of? HDAC9? deficient? mice? and? their? wild?type?
littermates? by? transcardial? India? ink? perfusion.? Evaluation? of? the? diameter? of? the? posterior?
communicating? arteries? (PComA)? (A,? arrows)? and? the? brain? surface? covered? by? the?MCA? and? its?
branches?(B,?dashed?line)?showed?no?influence?of?HDAC9?deficiency?on?vascular?anatomy.?
?
HDAC9?deficiency?leads?to?worse?outcome?during?7?days?survival?after?MCAo?
Long?term? functional?outcome?and?mortality?was?analyzed?during? the?7?days?observation?
period?after?MCAo.?Overall,?5?out?of?13?HDAC9?/??mice?died? in?comparison? to?4?out?of?14?
HDAC9+/+?mice? (Figure?4A;?P=0.51).?HDAC9?/??mice?showed?a? trend? toward? increased?body?
weight?loss?and?delayed?body?weight?recovery?during?the?7?days?(P=0.083?and?P=0.069?for?
day?6?and?7;?Figure?4B).?Motor?function?was?examined?prior?to?filament?removal?and?daily?
after?MCAo? (Supplementary? Figure? S1).? No? animal? reached? scores? higher? than? 2.5.? No?
difference?in?the?modified?Bederson?score?was?observed?at?the?end?of?the?1?hour?occlusion,?
indicating?that?comparable?areas?of?the?brain?were?equally?affected?by?MCAo? (Figure?4C).?
But?24?hours?after?MCAo,?8?out?of?13?HDAC9?/??mice?showed?severe?deficits? in?comparison?
to?5?out?of?14?HDAC9+/+?mice? (P=0.089,?Figure?4C).?7?days?after?MCAo?this?difference?was?
?
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even?more?prominent:?all?HDAC9?/??mice?displayed?persistent?deficits?while?this?was?the?case?
in?only?4?out?of?10?HDAC9+/+?animals?(P<0.01;?Figure?4C).?
?
?
Figure?4.?Outcome?7?days?after?MCAo.? (A)?There?was?no?difference? in?mortality?during? the?7?days?
observation?period.? (B)?HDAC9?deficient?mice?showed?a?trend?toward?worse?body?weight?recovery?
compared?to?their?wild?type?littermates.?(C)?HDAC9?deficient?mice?showed?worse?functional?outcome?
24?hours?and?7?days?after?MCAo.?**P<0.01.?
?
?
?
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HDAC9?deficiency?has?no?effect?on?cerebral?blood?flow,?animal?physiology,?and?brain?edema?
formation?
Monitoring? of? CBF? during? ischemia? and? reperfusion? revealed? no? differences? between?
HDAC9?/??and?HDAC9+/+?mice,?neither? in? the?degree?of?CBF? reduction?during? ischemia?nor?
during? reperfusion? (Figure? 5A).? Similarly,? there?were? no? differences? in? blood? gases? and?
mean? arterial?pressure?before? and? after? ischemia?between? groups? (Supplementary?Table?
S1).?Analysis?of?brain?edema?24?hours?after?MCAo?showed?similar?brain?water?contents? in?
the?non?affected?contralateral?hemisphere? (78.6%?±?0.3%? for?HDAC9+/+;?78.4%?±?0.4%? for?
HDAC9?/??mice;?mean? ±? SD)? and? the? infarcted? ipsilateral? hemisphere? (81.0%? ±? 0.8%? for?
HDAC9+/+;? 81.0%? ±? 0.7%? for? HDAC9?/??mice;?mean? ±? SD),? demonstrating? that? increased?
infarct? volumes? in? HDAC9? deficient? mice? were? not? associated? with? increased? edema?
formation?(Figure?5B).??
?
?
Figure?5.?Post?ischemic?reperfusion?and?edema?formation.? (A)?Cerebral?blood?flow?during? ischemia?
and?reperfusion?was?unaffected?by?HDAC9?deficiency.?(B)?Analysis?of?brain?water?content?24?hours?
after?MCAo? revealed? significant? edema? formation? in? the? ipsilateral?hemisphere.?However,?HDAC9?
deficiency?had?no? influence? either?on?basal?brain?water? content?or?on? the? formation?of? ischemic?
brain?edema.?***P<0.001.?
?
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HDAC9?deficiency?increased?the?number?of?TUNEL?positive?cells?in?the?peri?ischemic?region?
The?differences? in? infarct?volume?and?neurological? score?between?HDAC9?/??and?wild?type?
mice?were?more?pronounced?7?days?post?MCAo?which?could?be?a? result?of? increased?cell?
death? in? the? peri?ischemic? region.?We? analyzed? this? by? quantifying? TUNEL? positive? cells?
24?hours? after?MCAo? in? two? regions?of? interest,?one? at? the?border?of? the?MCA? and?ACA?
territory? (ROI1)?and?one?at? the?piriform?cortex? (ROI2),?a?region?specifically?prone? to?post?
ischemic?neuronal?cell?death.?We?observed?significantly?increased?cell?death?in?the?piriform?
cortex?of?HDAC9?deficient?mice?as?compared?to?wild?type?littermates?(ROI2?in?Figure?6A?and?
6B).?
?
?
Figure?6.?Quantification?of? the?number?of?cells?with?DNA?damage?24?hours?after?MCAo?by?TUNEL?
staining.?(A)?Representative?image?demonstrating?the?two?regions?of?interest?(ROI1?and?ROI2)?at?the?
peri?ischemic? region? for?quantification?of?TUNEL?positive? cells.? (B)?HDAC9?deficiency? resulted? in?a?
significantly?higher?number?of?TUNEL?positive?cells?in?the?piriform?cortex?(ROI2).?*P<0.05.?
?
?
Discussion?
The?results?of?the?current?study?suggest?that?HDAC9?may?have?a?neuroprotective?potential?
after?cerebral?ischemia.?This?is?demonstrated?by?larger?infarct?volumes?24?hours?and?7?days?
after?MCAo,?a?trend?toward?worse?body?weight?recovery?and?a?worse?neurological?outcome?
in?HDAC9?deficient?mice.?Moreover,?HDAC9?deficient?mice? showed? increased?numbers?of?
TUNEL?positive?cells? in?peri?ischemic?brain? tissue.?While? the?exact?mechanisms?mediating?
the? neuroprotective? effect? of? HDAC9? remain? unclear,? we? could? exclude? differences? in?
perfused?MCAo? territory? or? collateralization? as? underlying? cause.? Similarly,? reperfusion,?
?
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physiological?parameters?and?brain?edema?were?similar?between?HDAC9?deficient?mice?and?
wild?type?littermates.?
The?observed?increase?in?HDAC9?expression?levels?in?ischemic?brain?within?the?first?3?hours?
after?MCAo? is? in? agreement?with? similar? results?on? ischemic? core? and?penumbra? lysates?
obtained?from?rats?sacrificed?24?hours?after?transient?cerebral?ischemia.21?Further?evidence?
for?a?potential?role?of?HDAC9?in?neuroprotection?has?been?provided?by?in?vitro?data?showing?
that? expression?of? the?histone?deacetylase?related?protein? (HDRP),? an? isoform?of?HDAC9?
lacking?the?histone?deacetylase?domain,?is?reduced?in?rat?cerebellar?granule?neurons?when?
undergoing? apoptosis? induced? by? low? potassium? levels.14? By? overexpressing? HDRP,? cell?
death? could? be? successfully? inhibited.14? This? is?well? in? line?with? our? results? of? increased?
infarct?volume,?worse?functional?outcome?and?the?elevated?number?of?TUNEL?positive?cells?
in?HDAC9?deficient?mice? following? cerebral? ischemia.?One?possible? interpretation? for? the?
increased? HDAC9? expression? after? experimental? stroke? is? that? HDAC9? is? upregulated? in?
order?to?counteract?cell?death?signaling.?
Several? reports? describe? beneficial? effects? of? pan? HDAC? inhibitors? in? animal?models? of?
neurodegeneration,? such? as? Huntington? disease,22? amyotrophic? lateral? sclerosis,23? spinal?
muscular?atrophy,24?dementia25?and?stroke.11?13,26,27?Our?current?results?are?not?necessarily?
contradictory?to?these?findings,?since? inhibiting?more?than?one?HDAC? isoform?might?result?
in? pleiotropic? effects? obscuring? the? roles? of? individual? HDACs.?Moreover,? a? number? of?
HDAC?associated?processes,?in?particular?those?dependent?on?type?II?HDACs?such?as?HDAC9,?
have?been?shown? to?not? require?deacetylase?activity.? It? is? therefore?conceivable? that?pan?
HDAC?inhibitors?only?marginally?interfere?with?HDAC9?functions.?
We?and?others? recently? showed?an?attenuation?of?atheroprogression? in?HDAC9?/??mice.5,6?
These?results?are? in? line?with?recent?genome?wide?association?studies?which? identified?an?
association? of? the? HDAC9? gene? region? with? large? vessel? stroke1,2? and? coronary? artery?
disease,3? indicating? a? specific? involvement? of? HDAC9? in? atherosclerosis.? HDAC9? may?
therefore?represent?a?promising?pharmacological? target? for?the?treatment?of?this?disease.?
Since,?however,?patients?with?atherosclerosis?are?also?often?affected?by?ischemic?stroke?and?
our?results?suggest?a?protective?function?of?HDAC9?after?cerebral?ischemia,?specific?caution?
is? required? when? developing? HDAC9? inhibitors? for? the? treatment? of? atherosclerosis.? A?
possible?approach?could?be?to?develop?HDAC9?inhibitors?which?do?not?cross?the?blood?brain?
barrier?and?might?thus?have?no?or?minimal?effects?on?stroke?outcome.?
?
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In? summary,?our? current? results?demonstrate? that?HDAC9?deficiency? increases? cell?death?
and? worsens? long?term? outcome? following? transient? cerebral? ischemia.? This? suggests? a?
robust?and? long?lasting?protective?role?of?HDAC9? in?the? ischemic?brain?which?needs?to?be?
carefully?considered?when?exploiting?the?anti?atherogenic?potential?of?HDAC9?inhibitors.?
?
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Supplementary?Information?
?
?
Supplementary?Figure?S1?
?
?
Figure? S1.? Daily? neurological? examinations? resulted? in? a? trend? toward? worse?motor? function? in?
HDAC9?deficient?mice?which?reached?significance?7?days?after?MCAo.?**P<0.01.?
?
?
Supplementary?Table?S1.?Physiological?values?
?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ??
before?ischemia after?ischemia?
HDAC9
+/+
? HDAC9
?/?
? P?value HDAC9
+/+
? HDAC9
?/?
? P?value
MAP?(mmHg)? 124?±?21? 123 ± 16 n.s. 86 ± 21 90?±?25? n.s.
pH? 7.35?±?0.06? 7.36 ± 0.08 n.s. 7.29 ± 0.09 7.33?±?0.02? n.s.
pCO
2
?(mmHg)? 39.7?±?5.9? 36.4 ± 2.8? n.s. 35.7 ± 2.5? 37.5?±?3.3? n.s.
pO
2
?(mmHg)? 120.7?±?29.4? 166.6 ± 21.7? <?0.01 131.3 ± 15.6? 140.6?±?14.7? n.s.
Na
+
?(mmol/L)? 140?±?5? 139 ± 5? n.s. 144 ± 4? 144?±?5? n.s.
K
+
?(mmol/L)? 4.88?±?0.75? 4.71 ± 0.84? n.s. 6.14 ± 1.90? 5.95?±?1.34? n.s.
Ca
++
?(mmol/L)? 1.12?±?0.08? 1.11 ± 0.07? n.s. 1.10 ± 0.18? 1.14?±?0.08? n.s.
HCT?(%)? 43?±?5? 43 ± 6 n.s. 51 ± 8 49?±?7? n.s.
O
2
?Sat?(%)? 97.6?±?1.3? 98.3 ± 1.3? n.s. 97.3 ± 2.5? 97.7?±?1.4? n.s.
?? ?? ?? ?? ?? ?? ?? ?? ??
mean?±?SD,?HDAC9
+/+
:?n?=?7?8,?HDAC9
?/?
:?n?=?5?6,?MAP:?mean?arterial?pressure,?Mann?Whitney?U?
test,?n.s.:?not?significant?
?
?
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7???Discussion?
The?HDAC9?gene?locus?at?chromosome?7p21.1?was?recently?identified?as?a?risk?locus?for?LVS?
(Bellenguez?et?al.,?2012;?Traylor?et?al.,?2012).?The?7p21.1?locus?shows?only?association?with?
LVS?and?not?with?the?other?two?subtypes?of?ischemic?stroke,?cardioembolism?or?small?vessel?
disease.? Additionally,? this? locus? has? also? been? associated?with? CAD? and? carotid? intima?
media?thickness?(Deloukas?et?al.,?2013;?Markus?et?al.,?2013).?HDAC? inhibitors?have?already?
demonstrated?neuroprotective?and?anti?inflammatory?properties?in?several?studies,?making?
HDAC9?an? interesting? target? for?stroke?research.? In? the? first?part?of? this? thesis? the?role?of?
HDAC9? deficiency? was? analyzed? in? a? mouse? model? for? atherosclerosis,? which? is? the?
underlying? pathology? of? LVS? and? CAD.? In? the? second? part,? HDAC9? deficient?mice? were?
subjected? to?acute? ischemic?stroke?and?the? functional?as?well?as? the?histological?outcome?
was?investigated.??
?
HDAC9?deficiency?is?atheroprotective?
In? the? first?part?of? this? thesis,?we?got? further? insights? into? the?biological?role?of?HDAC9? in?
atherosclerosis.? Our? results? suggest? that? HDAC9? inhibition? is? a? promising? therapeutic?
strategy?for?prevention?of?atherosclerosis.?
The?hypothesis?of?an?atheroprotective?effect?of?HDAC9?deficiency?was?based?on?data?from?
my? colleague? Caroline? Prell?Schicker,?who? demonstrated? that?HDAC9?mRNA? levels?were?
significantly? increased? in? homozygous? and? heterozygous? risk? allele? carriers? of? the?
METASTROKE?lead?SNP?rs2107595?(Azghandi?et?al.,?2015).?The?two?other?neighboring?genes?
in? the?7p21.1? region,?TWIST1?and?FERD3L,?did?not? show?any?correlations?of?mRNA? levels?
with? allele? carrier? status,?making?HDAC9? the?most? promising? candidate? gene?within? this?
region.?The? increased?HDAC9?mRNA? levels? in?risk?allele?carriers? led?to?the?hypothesis?that?
HDAC9? deficiency/inhibition? should? be? protective.? We? confirmed? this? hypothesis,?
demonstrating?protective? effects?of?HDAC9?deficiency? in? a?mouse? atherosclerosis?model,?
ApoE?/??mice,?which?were?presented?in?manuscripts?1?and?2.?
HDAC9?/?ApoE?/??mice?had?significantly?reduced?atherosclerosis?throughout?the?aorta?at?two?
time?points?(Azghandi?et?al.,?2015).?However,?a?third?group?of?mice,?which?was?fed?a?high?
cholesterol? Western?type? diet,? showed? no? difference? in? plaque? size? between??
HDAC9?/?ApoE?/??and?HDAC9+/+ApoE?/??mice.?These?data?demonstrate?the?importance?to?study?
different?diets?and?time?points? in?experimental?atherosclerosis?models.?Our?Western?type?
?
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diet? data? help? to? understand? which? stage? of? atherosclerosis? is? affected? by? HDAC9?
deficiency.? We? conclude? that? HDAC9? is? mainly? important? in? early? atherogenesis.? This?
conclusion? is?based?on? the?observation? that? (1)?HDAC9?deficient?mice?on? chow?diet?had?
more? initial? lesions?than?wild?type? littermates,?(2)?the?degree?of?plaque?size?reduction?got?
smaller?with?increased?age?(18?week?old?vs?28?week?old?mice)?and?(3)?in?Western?type?diet?
fed?mice?with?more?advanced?plaques?differences? in?plaque?size?between?HDAC9+/+ApoE?/??
and? HDAC9?/?ApoE?/?? mice? could? no? longer? be? detected.? The? atheroprotective? effect? of?
HDAC9? deficiency?was? also? demonstrated? by? another? group? in? a? second? atherosclerosis?
model,? LDLR?/?? mice? (Cao? et? al.,? 2014),? showing? that? the? phenotype? is? very? robust,?
reproducible?and? independent?of?the?atherosclerosis?model.?LDLR?/??mice?have?to?be?fed?a?
high?cholesterol?diet?to?develop?atherosclerotic? lesions? in?contrast?to?ApoE?deficient?mice?
which?develop? atherosclerotic? lesions? spontaneously?on? a? chow?diet.?Another?difference?
between? the? two? mouse? models? is? that? for? bone? marrow? transplantation? into? ApoE?
deficient?mice,?the?donor?bone?marrow?has?to?be?ApoE?deficient? in?contrast?to?donors?for?
LDLR?/??mice?where? the?bone?marrow?can?have?an?LDLR?wild?type?genotype? (Linton?et?al.,?
1995;?Herijgers?et?al.,?1997).?This? shows? that? these? two?models?differ? in? the?mechanism?
inducing?atherosclerosis,?but? the? reproducible?effect?of?HDAC9?deficiency? in?both?models?
makes?HDAC9?inhibition?a?very?promising?strategy?for?humans.??
?
HDAC9?deficiency?influences?monocyte/macrophage?dynamics?
HDACs?are?known?to?play?an? important?role? in? inflammation?and? immunity?(Shakespear?et?
al.,? 2011).? Several? studies? have? shown? an? involvement? of? HDACs? in? innate? immunity.?
Classical? HDACs? influence?macrophage? and? dendritic? cell? function? by? targeting? Toll?like?
receptor?and? IFN???signaling? (Shakespear?et?al.,?2011).?Recent?studies?showed?that?HDACs?
such?as?HDAC3?and?HDAC7?regulate? inflammatory?gene?expression? in?macrophages? (Chen?
et?al.,?2012;? Shakespear?et?al.,?2013).?Macrophages? contribute? to? the?different? stages?of?
atherosclerosis?by?inducing?inflammatory?processes,?forming?foam?cells?and?eventually?the?
necrotic?core?of?an?advanced?plaque?(Moore?et?al.,?2013).?Macrophages?can?be?grouped?in?
M1? and?M2? macrophages.? Classically? activated? macrophages? of? the?M1? type? are? pro?
inflammatory?and?regarded?as?pro?atherogenic?while?M2?macrophages?are?characterized?by?
anti?inflammatory? cytokine? profiles? and? are? associated? with? wound? healing? and?
atherosclerosis?regression?(Moore?et?al.,?2013).??
?
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Cao? et? al.? observed? in? LDLR?/?? mice? that? HDAC9? deficient? macrophages? exhibited? an?
upregulated?expression?of?cholesterol?efflux?genes? such?as?ABCA1?and?ABCG1,?expressed?
less? pro?inflammatory? cytokines? after? LPS? stimulation,? and? demonstrated? an? M2?like?
phenotype? in?vitro? (Cao?et?al.,?2014).? In?ApoE?deficient?mice,?we?could? show? that?HDAC9?
deficiency? leads?to?a?Ly6C?shift? in?monocytes/macrophages,?meaning?HDAC9?/?ApoE?/??mice?
had? less? inflammatory? Ly6C+? and? more? resident,? patrolling? Ly6C?? monocytes? (see?
manuscript? 2).? It? is? known? that? hypercholesterolemic?ApoE?/??mice? have? an? expansion? of?
circulating?monocytes,?mainly?due?to?an?increase?in?Ly6C+?monocytes?(Swirski?et?al.,?2007).?
Monocytosis?in?atherosclerotic?mice?results?from?increased?survival,?continued?proliferation?
and?lower?conversion?rates?from?Ly6C+?to?Ly6C??monocytes?(Swirski?et?al.,?2007).?Besides?a?
Ly6C? shift? to? more? Ly6C?? monocytes,? we? observed? a? reduced? monocyte? frequency? in?
HDAC9?/?ApoE?/??mice?in?comparison?to?HDAC9+/+ApoE?/??mice.??
Additional?analysis?of?survival,?proliferation?and?conversion?rates?of?HDAC9?deficient?Ly6C+?
monocytes? could? give? further? insights? into? the? involvement? of? monocytes? in? the?
atheroprotective?mechanism?of?HDAC9?deficiency.?In?our?group,?we?are?currently?assessing?
migration?and?cytokine?expression?of?macrophages?exposed?to?different?pro?inflammatory?
stimuli?to?understand?how?monocytes/macrophages?contribute?to?the?observed?phenotype?
in?HDAC9?/?ApoE?/??mice.?
?
HDAC9?deficiency?affects?memory?T?cell?distribution?
Besides?monocytes/macrophages,?we? also? analyzed? T? cell? distribution? in?HDAC9?/?ApoE?/??
mice? on? chow? and? on?Western?type? diet? using? flow? cytometry.?We? did? not? detect? any?
differences?in?T?cell?frequency?or?in?the?relative?amount?of?CD4+?and?CD8+?subpopulations.?
HDAC9?has? already?been? known? as? an? important? regulator?of? the? function?of? regulatory??
T?cells?(Tao?et?al.,?2007).?Tao?et?al.?showed?an?increase?in?Tregs?by?50%?in?HDAC9?deficient?
mice.?In?contrast,?we?did?not?see?any?differences? in?frequency?of?Tregs? in?HDAC9?deficient?
mice?without?ApoE?deficiency?(see?manuscript?2).?This?is?probably?due?to?different?wild?type?
controls?that?were?used?in?the?studies.?We?always?used?wild?type?littermates?as?controls?in?
order? to? exclude?background? differences.? It? is?not? clear?whether? Tao? et? al.?used?normal?
C57BL/6?mice?or? littermates?as?controls.?Furthermore,?only?a? low?number?of?spleens?were?
analyzed? in? their? study? (n? =? 4).? In? our? HDAC9?/?ApoE?/?? mice,? we? measured? a? modest?
decrease?in?Treg?frequencies,?in?chow?and?Western?type?diet?fed?mice.?We?do?not?believe,?
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however,?that?this?decrease?has?a?physiological?importance?or?that?it?means?that?HDAC9?is?
not? important?for?Tregs.?Tao?et?al.?could?show?that?Tregs?have?higher?HDAC9?mRNA? levels?
than?effector?T?cells,? that?Treg? stimulation? induces?nuclear?export?of?HDAC9,?and?HDAC9?
deficient?Tregs?were?three??to?fourfold?more?suppressive?than?controls?and?had? increased?
FoxP3? acetylation? (Tao? et? al.,? 2007).? Therefore? additional? experiments? are? necessary? to?
delineate?the?function?of?Tregs?in?HDAC9?/?ApoE?/??mice.??
Moreover,?our?FACS?data?revealed?a?very?interesting?difference?in?another?T?cell?population,?
the?effector?memory?T?cells.?HDAC9?/?ApoE?/??mice?on?chow?diet?had?significant?less?effector?
memory? T? cells?within? the? CD4+? population? (see?manuscript? 2).? The? decreased? effector?
memory?T?cells?indicate?decreased?activation?and?mobilization?of?T?cells?in?HDAC9?deficient?
mice,?which? fits?with? the? reduced?atherosclerotic?plaque?size? in?chow? fed?HDAC9?/?ApoE?/??
mice.?A?recent?study?demonstrated?a?correlation?of?CD4+?effector?memory?T?cells?with?the?
extent?of?atherosclerosis?in?animals?and?carotid?intima?media?thickness?as?well?as?coronary?
artery?disease? in?humans? (Ammirati?et?al.,?2012),?suggesting? that?effector?memory?T?cells?
may?represent?an?important?immune?cell?population?in?atherogenesis.?
Our?data?from?monocytes/macrophages?and?T?cells?in?HDAC9?/?ApoE?/??mice?show?that?both?
innate?and?adaptive? immunity?might?play?an? important?role? in?the?atheroprotective?effect?
mediated?by?HDAC9?deficiency.??
?
HDAC9?deficiency?worsens?ischemic?stroke?outcome?
All? identified? loci? in?the?METASTROKE?data?set?showed?only?association?with?one? ischemic?
stroke?subtype,?emphasizing?the?importance?of?distinguishing?the?different?stroke?subtypes?
from?each?other?(Traylor?et?al.,?2012).?The?HDAC9?gene?region?showed?exclusive?association?
with?large?vessel?stroke,?where?the?underlying?pathology?is?atherosclerosis.?This?is?why?we?
analyzed? the? effects? of? HDAC9? deficiency? in? a?mouse? atherosclerosis?model.? However,?
several?studies?have?already?demonstrated?beneficial?effects?of?HDAC? inhibitors? in?models?
for? stroke? and? neurodegenerative? diseases? (Kazantsev? and? Thompson,? 2008;? Shein? and?
Shohami,? 2011).? In? the? second? part? of? this? thesis,? the? role? of?HDAC9? in? ischemic? stroke?
outcome? was? analyzed? by? using? the? MCAo? model? in? HDAC9? deficient? mice? (see?
manuscript?3).?Surprisingly,?HDAC9?deficient?mice?demonstrated? larger? infarct?volumes?24?
hours?and?7?days?after?ischemic?stroke.?The?increase?in?infarct?volume?was?also?reflected?in?
worse?neurological?scores.?We?checked?blood?pressure,?blood?gases?and?vascular?anatomy??
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(MCA?territory?as?well?as?the?degree?of?collateralization?between?the?anterior?and?posterior?
cerebral?circulation)?and?did?not?detect?any?differences.?Also?brain?edema? formation?and?
reperfusion?were?not?affected?by?HDAC9?deficiency.?The?detailed?mechanism?of? increased?
infarct?volume?and?worse? functional?outcome? is?still?unclear?but?we?hypothesize? that? the?
worse?outcome?is?based?on?increased?cell?death?due?to?our?finding?of?elevated?numbers?of?
TUNEL? positive? cells? in? peri?ischemic? areas? of?HDAC9? deficient?mice.?Moreover,? another?
study? already? demonstrated? that? an? HDAC9? isoform,? lacking? the? deacetylase? domain,? is?
important?for?neuronal?survival?in?vitro?(Morrison?et?al.,?2006).?We?also?detected?increased?
levels? of?HDAC9? in? peri?infarct? regions? of?wild?type?mice? in? the? first? hours? after? stroke,?
indicating?that?cells?may?upregulate?HDAC9?to?counteract?cell?death?signaling.??
Since?the?promising?atheroprotective?results?of?HDAC9?deficiency?make?HDAC9?a?potential?
drug? target? to?prevent?atherosclerosis,?development?of?HDAC9? inhibitors? should?consider?
negative? effects? of? these? inhibitors? in? the? brain.? The? potential? patient? target? group? for?
HDAC9? inhibitors? are? people? at? risk? for? atherosclerosis?who? are? also? at? risk? for? stroke.?
Therefore? it? is? important?to?understand? in?more?detail?the?effect?of?such? inhibitors?on?the?
brain.??
HDAC9?belongs?to?the?class?IIa?HDACs?for?which?the?exact?mechanism?of?repression?has?not?
been? fully? discovered.? Class? IIa? HDACs? have? a? minimal? catalytic? activity? and? therefore?
regulate? transcription? by? interacting? with? other? multiprotein? complexes? containing??
class? I? HDACs,? like? HDAC3? (Fischle? et? al.,? 2002;? Lahm? et? al.,? 2007).? HDAC9? has? several?
isoforms? including? some? without? a? deacetylase? domain,? demonstrating? that? catalytic?
activity?is?not?necessary?for?its?function?(Petrie?et?al.,?2003).?This?could?also?explain?why?pan?
HDAC? inhibitors?are?neuroprotective?while?HDAC9?deficiency?worsens?neuronal?cell?death.?
The?catalytic?activity?of?HDAC9?may?not?be? important?for? its?function? in?neuronal?survival.?
Therefore? it? is?of?utmost? importance? to?understand? the?molecular?mechanism?underlying?
the?atheroprotective?effect?of?HDAC9?deficiency? in? comparison?with? the?neuroprotective?
effect?of?HDAC9.??
? ?
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Outlook?
Since?the?results?of?this?thesis?make?HDAC9?a?potential?drug?target?for?atherosclerosis?and?
stroke?prevention,?the?exact?mechanisms?underlying? its?effects?have?to?be?discovered.?On?
the?one?hand,? responsible? cell? types? for? the?atheroprotective?effect?of?HDAC9?deficiency?
have? to?be? identified.?The?data? reported? in? this? thesis? suggest? that?a? combined?effect?of?
several? cell? types? is? responsible? for? the? reduced? atherosclerosis? phenotype? in??
HDAC9?/?ApoE?/??mice.? In?our?group? several? in?vitro?approaches?are?under? investigation? to?
test? different? cell? types,? including? macrophages,? T? cells? but? also? smooth? muscle? and?
endothelial?cells.?My?colleague?Yaw?Asare?has?already?obtained?promising?results,?showing?
that?also?smooth?muscle?cells?and?endothelial?cells?express?less?atherogenic?molecules?after?
HDAC9?knockdown?in?combination?with?inflammatory?stimulation.?Besides?the?cell?type,?the?
underlying?pathway?by?which?inhibition?of?HDAC9?influences?inflammatory?signaling?has?to?
be?elucidated.?These?experiments?can?be?done?in?animal?models?but?the?results?have?to?be?
transferred?to?humans.? Immune?cells?seem? like?a?promising?target?considering?the?HDAC9?
expression?data? in?human?PBMCs?and?my?own?data?showing?that?monocytes?and?effector?
memory? T? cells? are? candidate? cells? for? HDAC9? inhibition.?My? colleague? Caroline? Prell?
Schicker?has?already? investigated?FoxP3?and?HDAC9?expression? in?Tregs? isolated? from?risk?
allele?carriers?of? the? rs2107595? lead?SNP.?However,?she?did?not?detect?any?differences? in?
expression.?Based?on? the? results?of? this? thesis,?we?now?plan? to? investigate?other? immune?
cell? types? in? risk? allele? carriers? of? rs2107595,? such? as? monocytes? and??
CD4+?effector?T?cells.?Another? interesting?question,?which?our?group? is?addressing,? is?how?
variants?at?this?locus?regulate?HDAC9?expression.?For?another?locus,?the?1p13? locus,?which?
was?found?to?be?associated?with?myocardial? infarction?and?plasma? low?density? lipoprotein?
cholesterol?by?GWAS,?Musunuru?et?al.?could? show?how?noncoding?variants?can? lead? to?a?
clinical? phenotype.? The? risk? allele? creates? a? new? transcription? binding? site? for??
C/EBP? transcription? factors? which? leads? to? increased? liver?specific? expression? of? the?
transporter?protein?Sortilin?(Musunuru?et?al.,?2010).?Our?lead?SNP?rs2107595?is?located?in?a?
DNase? I? hypersensitity? cluster? and? histone?modification? hotspot,? indicating? a? regulatory?
function?(Azghandi?et?al.,?2015).? Indeed,?the?TRANSFAC?database?(Wingender?et?al.,?2000)?
predicts?that?the?risk?allele?of?rs2107595?disrupts?a?binding?site?for?the?E2F3?transcription?
factor.?This?is?a?new?project?under?investigation?in?our?group.??
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Conclusion?
In? summary,? the? results? of? this? thesis? give? insights? into? the? beneficial? effect? of? HDAC9?
deficiency? in? atherosclerosis.?We? provide? further? evidence? that? HDAC9? is? the? disease?
relevant?gene?at?the?7p21.1?locus?associated?with?LVS?and?CAD,?demonstrating?how?GWAS?
can?identify?new?target?genes?for?complex?diseases.?We?could?show?that?HDAC9?deficiency?
reduces? early? atherogenesis? and? propose? an? immune?cell?mediated?mechanism? by? both?
innate?and?adaptive? immunity.?HDAC9?deficiency?has?an?effect?on?monocyte/macrophage?
dynamics?as?well?as?on?effector?memory?T?cells.?Our?results?suggest?that?pharmacological?
inhibition? of? HDAC9? might? be? a? promising? therapeutic? strategy? for? the? prevention? of?
atherosclerosis?and?LVS.?Additional?experiments?are?necessary?to?discover?the?mechanism?
by? which? variants? at? this? locus? regulate? HDAC9? expression? and? how? HDAC9? influences?
inflammatory?signaling?in?the?identified?immune?cell?types.?
In? addition? to? atherosclerosis,? we? also? investigated? ischemic? stroke? outcome? in? HDAC9?
deficient? mice.? HDAC9? deficiency? seems? to? aggravate? infarct? volume? and? neurological?
outcome?after?acute?ischemic?stroke,?indicating?that?HDAC9?has?a?neuroprotective?function?
in? the? brain.? Therefore? the? data? presented? in? this? thesis? strongly? suggest? that? potential?
negative?effects?of?HDAC9?inhibitors?on?the?brain?have?to?be?considered?in?the?development?
of?respective?compounds.? ?
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